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This thesis describes a series of experiments that were designed to improve the 
generation and handling of skin stem cells used for clinical transplantation. 
The research work was carried out in the Department of Plastic, 
Reconstructive and Aesthetic Surgery at Singapore General Hospital (SGH), 
where severe burns patients are admitted for treatment in the Burns Unit. 
Cultured human keratinocytes have been successfully used to prepare cultured 
epithelial autografts (CEA), for permanent coverage of full-thickness burn 
wounds and skin defects. This cell therapy has saved the lives of many 
patients in the Burns Unit of SGH, and in other hospitals worldwide as well. It 
has been reported in previous publications that epidermal stem cells are 
present in the CEAs, and these cells constantly renew and maintain the 
regenerated epidermis. Therefore it is vital to isolate and identify epidermal 
stem cells, and maintain these stem cells in the CEAs. The aim of this thesis 
work was to improve the cultivation and enrichment of human epidermal stem 
cells. Such improvement should improve the performance of CEA after 
transplantation and might be used for other cell therapy strategies as well.  
 
The first part of my thesis deals with the cultivation of epidermal stem cells. 
The current culture system for keratinocytes is based on mouse 3T3 feeder 
layer cells. Therefore in order to exclude animal products in CEAs and to 
simplify the cultivation protocol, I developed a novel feeder-free and serum-
free culture medium for keratinocytes. This forms the second chapter of my 
thesis after the general introduction on epidermal stem cells.  
 
Next, I began the search for specific cell surface markers which can 
specifically identify epidermal stem cells and which can be used to purify and 
enrich human epidermal stem cells. In an attempt to purify epidermal stem 
cells from human hair follicle, a population of hair follicle sheath derived 
mesenchymal stem cells was identified, and characterized.   
 
Focusing on the human interfollicular epidermis, I evaluated the published 
molecular markers for identification of epidermal stem cells. Out of these 
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markers, I concentrated on ABCG2, a cell membrane transporter, which was 
reported to be a universal stem cell marker. The expression of ABCG2 in 
human skin was studied, and its potential of purifying epidermal stem cells 
was investigated both in vitro and in vivo.  The data indicate that ABCG2 is 
exclusively expressed by basal keratinocytes in human interfollicular 
epidermis and this ABCG2-positive population of cells possesses all the 
epidermal stem cell properties. These findings of ABCG2 were novel and 
form the basis of my thesis on epidermal stem cells.  
 
The improved cultivation and enrichment of epidermal stem cells described 
here will benefit patients with severe burns or patients with large skin defects. 
It will potentially pave the way for a safer method of cultivating epidermal 
stem cells for clinical applications.   
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1.1.1 EPIDERMAL STEM CELLS 
The skin epidermis and its appendages provide a protective barrier which is 
impermeable to microbes and prevents dehydration, it also protects against 
chemical and physical damage, it is a sensory organ, an immunologically 
active organ, a sensory organ and it has storage function (Fig. 1.1). The skin 
undergoes continual self-renewal through homeostasis and wound repair in 
response to injury. The skin’s ability of maintaining tissue homeostasis, 
regenerating tissues and repairing wound is dependent on the epidermal stem 
cells and other cell types.  
Fig.1.1 Anatomy of human skin and hair follicle. The human skin is composed of 
three layers: epidermis, dermis and hypodermis. The epidermis is a stratified 
squamous epithelium which is divided into four layers: stratum corneum (SC), 
stratum granulosum (SG), stratum spinosum (SS) and stratum basale (SB). The stem 
cells niche within skin include the basal layer of epidermis, sebaceous gland, hair 




1.1.1 Definition of Stem Cells  
A stem cell has been defined as “A cell capable of renewing tissue for the 
lifetime of an organism” (Lajtha 1979) or “The cell in a tissue which, under 
normal circumstances, maintains its own population, undiminished in function 
and size, and furnishes daughters to provide new functional cells of that 
tissue” (Schofield 1983). Stem cells have both the capacity for self-renewal, 
i.e., the ability to generate additional stem cells, and the capacity to generate 
progeny that are fated to give rise to differentiated descendent (Morrison, 
Wright et al. 1997; Watt and Hogan 2000), these cells were also called transit 
amplifying (TA) cells while they retain limited proliferative capacity (Lajtha 
1979). Continuous renewal and repair of most tissues and organs throughout 
life depends on the proliferation and differentiation of tissue-specific stem 
cells.  
 
1.1.2 Location of epidermal stem cells 
Epidermal stem cells are thought to be located in the basal layer of the 
interfollicular epidermis, in the bulge region of the hair follicle and in the 
sebaceous gland (Blanpain, Lowry et al. 2004; Cotsarelis 2006; Kaur 2006; 
Moore and Lemischka 2006). Within the interfollicular epidermis, epidermal 
stem cells are dispersed throughout the basal layer, constituting between 1-
10% of basal layer keratinocytes (Potten and Hendry 1973). Epidermal stem 
cells within the hair follicle are located in a well-protected niche - the bulge 
region, which is localized at the insertion site of the arrector pili muscle 
(Cotsarelis, Sun et al. 1990; Morris and Potten 1999; Cotsarelis 2006). Recent 
studies have shown that there are other multipotent epidermal stem cells 
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niches within the hair follicle (Haegebarth and Clevers 2009), sebaceous gland 
(Jensen, Collins et al. 2009) and sweat gland (Biedermann, Pontiggia et al. 
2010; Lu, Polak et al. 2012).  
 
1.1.3 Properties of epidermal stem cells 
1.1. 3.1  Slow cycling and label retaining  
It is widely believed that stem cells are virtually dormant and only divide very 
rarely - they are “slow cycling” cells (Potten, Kovacs et al. 1974; Lajtha 
1979). The skin epidermis and hair follicle contain slow-cycling cells which 
were identified by their capacity to retain BrdU and/or radio-labeled DNA 
precursors for a long period (Potten, Kovacs et al. 1974; Bickenbach 1981; 
Mackenzie and Bickenbach 1985; Morris, Fischer et al. 1985).(Rheinwald and 
Green 1975) This property of slow cycling and label retention in vivo, is now 
widely used as a characteristic behavior of identification of stem cell 
populations.  
 
1.1.3.2  Clonogenicity 
When cultivated in appropriate conditions, some keratinocytes can form a 
colony. These keratinocytes are named clonogenic or colony forming 
cells(Rheinwald and Green 1975). According to the growing potential of these 
colony forming cells, these cells are classified into three categories: (1) 
holoclones, cells have the greatest proliferative capacity, therefore are 
considered to be epidermal stem cells; (2) paraclones, cells have a short 
replicative lifespan (less than 15 divisions); (3) meroclone, cells in a 
transitional state between holoclones and paraclones (Barrandon and Green 
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1985; Barrandon and Green 1987). These 3 cell types are present in the normal 
interfollicular epidermis and hair follicle (Rochat, Kobayashi et al. 1994).  
 
1.1.3.3  Transcript profile 
Recent microarray studies have revealed that epidermal stem cells have a 
specific profile of gene expression when compared to transit amplifying cells 
and differentiated keratinocytes. In epidermal stem cells, a group of genes are 
turned on (including DKK3, WIF1, FZD1, Tcf3, FST, TGFβ2, and LTBP1) 
which define a slow-cycling phenotype (Morris, Liu et al. 2004; Tumbar, 
Guasch et al. 2004; Jensen and Watt 2006). This transcriptional activity 
involves Wnt/β-catenin, BMP and TGFβ signaling, which negatively regulate 
the proliferation and differentiation of epidermal stem cells, and maintain 
them in an undifferentiated state (Jensen and Watt 2006).  
 
1.1.3.4  Multipotency and unipotency 
The epidermal stem cells in the hair follicle bulge region show multipotency - 
they can give rise to all lineages of skin epithelia, including interfollicular 
epidermis, hair follicle, sebaceous gland and sweat gland (Oshima, Rochat et 
al. 2001; Claudinot, Nicolas et al. 2005).  Under normal physiological 
conditions, the bulge epidermal stem cells maintain the self-renewal of the hair 
follicle and the related sebaceous gland, and do not participate in the renewal 
of interfollicular epidermis. In response to wound healing or other stimuli, the 
bulge stem cells can contribute to the renewal of the interfollicular epidermis 
for a short period before disappearing (Taylor, Lehrer et al. 2000; Oshima, 
Rochat et al. 2001; Claudinot, Nicolas et al. 2005). Under homeostatic 
15 
 
conditions, the interfollicular epidermal stem cell is responsible for the 
lifelong renewal of epidermis without the need for progeny from the hair 
follicle bulge stem cells (Ito, Liu et al. 2005; Levy, Lindon et al. 2005). The 
interfollicular stem cells can only give rise to keratinocytes, in other words, 
they only show the capacity of unipotency (Alonso and Fuchs 2003).  
 
1.1.4 Identification of epidermal stem cells 
Currently, there are several methods used to experimentally identify epidermal 
stem cells, and distinguish them from transit amplifying keratinocytes.  
 
The first method is to inject skin with a pulse of 5-bromo-2-deoxyuridine 
(BrdU) or [3H] thymidine, whereupon the BrdU or [3H] thymidine will be 
incorporated into the newly synthesised DNA of replicating keratinocytes 
(stem cells and transit amplifying cells). After a variable period of time, in 
which the skin cells will divide according to their state, the skin is sampled 
and probed for the presence of the incorporated tracer. As epidermal stem cells 
divide rarely, they will not dilute the label but will retain it at its original 
concentration over a long period of time, and these cells are therefore referred 
to as label-retaining cells (LRC). In contrast the label in actively dividing 
transit amplifying cells will be lost through dilution in dividing process 
(Bickenbach 1981) (Cotsarelis, Sun et al. 1990). 
 
The second approach is to distinguish epidermal stem cells from transit 
amplifying cells by the different proliferative potential of single cultured cells, 
a method that can be used for both human and rodent keratinocytes. Analysis 
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of the resulting epidermal clones led to classification of keratinocyte types into 
stem-like, persistently proliferative holoclones and more abortive mero- and 
paraclones (Barrandon and Green 1987), as described above. Several studies 
have shown that LRC isolated from skin of adult mice (Morris and Potten 
1994) or rats (Pavlovitch, Rizk-Rabin et al. 1991; Kobayashi, Rochat et al. 
1993) also are very clonogenic in culture. 
 
1.1.5 Molecular marker of epidermal stem cells 
Epidermal stem cells have also been distinguished from transit amplifying 
cells by their unique cell surface phenotype. Within the human and mouse 
epidermis, a subpopulation of keratinocytes showed a higher expression of 
α6β1 integrin and low level of the transferrin receptor CD71,  compared to 
transit amplifying cells (Jones, Harper et al. 1995; Li, Simmons et al. 1998; 
Tani, Morris et al. 2000; Braun, Niemann et al. 2003). These cells were 
identified as rapidly adhering keratinocytes, found in the shallow rete ridges of 
the epidermis. Their lack of keratin 10 expression (i.e. undifferentiated) and 
BrdU incorporation in vitro suggested their slow cycling status (Jensen, 
Lowell et al. 1999). These cells also showed high colony forming efficiency in 
in vitro culture (Jones and Watt 1993; Jones, Harper et al. 1995; Li, Pouliot et 
al. 2004). Given the vast proliferative capacity of most basal layer 
keratinocytes, these markers only partially enrich epidermal stem cells (Li, 
Pouliot et al. 2004).  
 
Human and mouse hair follicle stem cells have been characterised by a strong 
expression of keratin 15 (K15) and keratin 19 (K19) (Michel, Torok et al. 
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1996; Lyle, Christofidou-Solomidou et al. 1998; Liu, Lyle et al. 2003; Morris, 
Liu et al. 2004). In mouse skin, expression of α6 integrin (in combination with 
low levels of the transferrin receptor CD71) and K19 have been correlated 
with [3H] thymidine-LRC assay, indicating that these markers can identify 
murine epidermal stem cells (Michel, Torok et al. 1996; Tani, Morris et al. 
2000). However as slow-cycling cells cannot be marked in human skin, it is 
not confirmed whether these markers specifically identify human epidermal 
stem cells.  
 
Another marker extensively investigated is CD34, a cell surface glycoprotein. 
CD34 is expressed on early haematopoietic progenitor cells in the human, and 
it has been used for isolation and purification of bone marrow stem cells 
(Brown, Greaves et al. 1991; Krause, Ito et al. 1994). Interestingly, CD34 was 
also shown to be expressed in the mouse hair follicle bulge region, and CD34-
positive keratinocytes, purified by fluorescence activated cell sorting (FACS), 
were shown to have clonogenic potential in vitro (Trempus, Morris et al. 
2003). To date, CD34 is regarded as one of the most compelling cell-surface 
markers for epidermal stem cells in mouse skin. However, CD34 is not 
detected within human skin and hair follicle.  
 
Another extensively characterized molecular marker is p63, a homologue of 
the p53 tumour suppressor gene. It belongs to a family that includes 
structurally related proteins such as p53 and p73. P63 was found to be highly 
expressed in holoclones and greatly reduced in meroclones and paraclones, 
and transit amplifying keratinocytes show greatly reduced p63 level 
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(Pellegrini, Dellambra et al. 2001). However, p63 expression alone is not 
sufficient to identify epidermal stem cells in vivo, as it is expressed in all basal 
keratinocytes as well as in a significant number of suprabasal cells of the 
epidermis and of the outer root sheath of the hair follicle. Moreover, p63 is 
also highly expressed in the hair matrix, which is thought to contain only cells 
with limited growth capacity. 
More recently, studies have shown that epidermal stem cells can also be 
distinguished from transit amplifying cells at the molecular level. Microarray 
studies and quantitative RT-PCR have revealed that epidermal stem cells in 
murine hair follicle (Morris, Liu et al. 2004; Tumbar, Guasch et al. 2004; 
Claudinot, Nicolas et al. 2005) and human epidermis (Ohyama, Terunuma et 
al. 2006) exhibit a specific gene expression profile compared to non-bulge 
transit amplifying cells. These data provide further insight in the molecular 
processes that underlie stem cell phenotypes. 
 
1.1.6 Clinical application of epidermal stem cells  
Human epidermal stem cells can be cultured in vitro under appropriate 
conditions, leading to the preparation of cultured epithelium sheets. By 
treating with Dispase, the epithelial sheet can be removed from culture dishes, 
and transplanted to re-epithelialise burn wounds, chronic wounds and ulcers 
(Gallico, O'Connor et al. 1984; Ronfard, Rives et al. 2000). This technology is 
effective in providing a temporary wound cover and reducing infection rates, 
but the epithelial sheet is fragile and does not adhere well to some skin 
wounds.  Moreover, It is time-consuming to prepare cultured epithelial sheets 
in vitro, and therefore expensive. Hair follicle epidermal stem cells have been 
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used to prepare skin equivalents, and can form epithelium in deep burn 
wounds after implantation (Hoeller, Huppertz et al. 2001; Navsaria, Ojeh et al. 
2004). This makes it possible to culture autologous epithelial grafts in vitro in 
a short time. As the hair follicle stem cells show multipotency and can 
differentiate into almost all epithelial cell types, hair follicle stem cell can be 
used to prepare composite skin substitutes. In the near future, it might be 
possible to prepare a real composite skin substitute, which involves the 
epidermis, dermis and skin appendages.  
 
The epidermal stem cells have other potential clinical applications besides 
epidermal replacement for burned skin or other skin wounds. Cultured human 
keratinocytes have been used as delivery instruments for gene therapy, and 
have shown success in correcting inborn skin diseases (Chen, Kasahara et al. 
2002; Ortiz-Urda, Thyagarajan et al. 2002; Mavilio, Pellegrini et al. 2006). 
Holoclone keratinocytes were harvested from patients with recessive 
dystrophic epidermolysis bullosa, and the genetic defect was corrected either 
by genomic integration of the correct sequence using a bacteriophage integrase 
or by transgene expression using a lentivirus. The repaired keratinocytes were 
expanded in culture and later grafted back to the original patient, in which the 
genetic defect was observed to be fully functionally corrected in the 
engineered skin grafted areas (Mavilio, Pellegrini et al. 2006). This technology 





1.2 SKIN SELF-RENEWAL, WOUND HEALING AND 
REGENERATION 
It is now widely accepted that the skin elements (epidermis, dermis and skin 
appendages) are constantly renewed by stem cells, and that in this process, at 
least six types of adult stem cells are involved in generating more than 25 cell 
lineages (Brouard and Barrandon 2003).  
 
1.2.1 Epidermis self-renewal 
In the skin epidermis, the basal layer keratinocytes actively divide, before 
moving upwards, replacing suprabasal keratinocytes and becoming committed 
to terminal differentiation. Label-retaining assays suggested that epidermis is 
organized in independent functional hexagonal column, named an epidermal 
proliferative unit (EPU) (Kolodka, Garlick et al. 1998; Asplund, Guo et al. 
2001; Ghazizadeh and Taichman 2001; Potten, Booth et al. 2002). According 
to the EPU theory, one epidermal stem cell is located at the center of the basal 
layer of each unit, and rapidly proliferating transit amplifying (TA) cells are 
located in the peripheral region of the EPU (Mackenzie 1970). The central 
epidermal stem cells have the greatest proliferative potential, but they stay 
quiescent and divide infrequently in normal conditions. In contrast, the TA 
cells divide rapidly to expand the progeny of stem cells, until after several 
rounds of division, they finally generate post-mitotic keratinocytes 
(Kobayashi, Rochat et al. 1993; Jones, Simons et al. 2007).  
 
Recently, the EPU model has been challenged (Clayton, Doupe et al. 2007; 
Jones, Simons et al. 2007). By using an in vivo inducible genetic labeling in a 
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mouse model, the fate of epidermal stem cells in tail epidermis was observed. 
The range of clone sizes generated by epidermal stem cells was not consistent 
with what was expected in EPU model, and it was proposed that the epidermis 
is maintained by a homogeneous population of long-lived progenitor cells, 
which can randomly switch between symmetric (producing two differentiating 
cells or two stem cells) and asymmetric divisions (producing one stem cell and 
one differentiating cell). The observation has now been repeated in different 
body sites in the mouse, but it remains to be demonstrated whether this is true 
in human and mouse interfollicular epidermis.  
        
Figure.1.2. The organization of epidermal proliferative unit (EPU) in mouse skin. 
The mouse interfollicular epidermis is histologically organized into columns termed 
the EPUs, EPU is consists of about 10 basal cells: a single stem cell (red) and its 
immediate progeny – transit amplifying (TA) cells (blue). The differentiated 
keratinocytes lying directly above them (yellow) and mature enucleated squames in 
an ordered stack above the basal layer. This figure illustrates both sectional and 




1.2.2. Dermal stem cells  
In skin dermis, fibroblasts are the main resident cells. They are a highly 
heterogeneous cell population. Different fibroblasts can be isolated from the 
papillary dermis, the reticular dermis, dermal sheath and dermal papilla of hair 
follicles, which show distinct growth potential, cell surface phenotype and 
transcriptional patterns (Sorrell and Caplan 2004; Rinn, Bondre et al. 2006; 
Rinn, Wang et al. 2008).  
 
So far, the dermal stem cell population is not well defined. It has been 
demonstrated that mesenchymal stem cells are distributed within the dermis, 
they are able to differentiate into at least one mesenchymal lineage, and they 
seem to be related to the existence of a perivascular niche (Freitas and Dalmau 
2006; Sudo, Kanno et al. 2007). Apart from mesenchymal stem cells, several 
groups have demonstrated that multipotent stem cells can also be isolated from 
the dermis. These cells (skin derived precursors, SKP) can differentiate into 
non-mesenchymal cell lineages (Toma, Akhavan et al. 2001). The SKP cells 
seem to be related to neural crest derived cells (Wong, Paratore et al. 2006; 
Fernandes, Toma et al. 2008).  
 
1.2.3 Skin wound healing and regeneration 
Skin wound healing comprises the restoration of epidermis and replacement of 
the dermal defect by granulation tissue, later remodeled into a connective 
tissue. The skin wound healing process is divided into three overlapping stages 




1.2.3.1  Inflammatory phase – clot formation 
In the case of a dermal wound, platelets immediately aggregate and activate 
the coagulation cascade, which results in the formation of fibrin clot. The 
platelets release multiple cytokines, growth factors and chemotactic 
substances (EGF, PDGF, IGF-1 and TGF-β). These factors attract 
inflammatory cells that migrate to the wound site, where they have a crucial 
function against bacteria and in the phagocytosis of cell and matrix debris. 
Additional cytokines (TNF-α, IL-1, TGF-α, HB-EGF, FGF and VEGF) are 
released which activate the keratinocytes and fibroblasts. Fibroblasts produce 
large quantities of extracellular matrix (ECM) components for replacement of 
dermal structure, and they may change their phenotype by acquiring 
contractile properties, becoming myofibroblasts.  
 
1.2.3.2  Proliferation phase – granulation tissue formation and re-
epithelialization 
In this phase, inflammatory signals activate cell proliferation and migration. 
Keratinocytes and fibroblasts secrete metalloproteinases (MMP-9, MMP-1) 
and serine protease (tPA, uPA), which can actively degrade the basement 
membrane and the ECM components (Mauch 1998). Keratinocytes also 
change their expression pattern of intermediate filaments and adhesion 
molecules (keratin6a/6b, keratin 16, keratin 17, α3β1-integrin) (DePianto and 
Coulombe 2004; Santoro and Gaudino 2005), to facilitate their migration in 
the extracellular matrix. With the stimulus of VEGF and FGF-2, numerous 
novel endothelial cells and fibroblasts and macrophages invade the fibrin clot, 
which is gradually replaced by granulation tissue. At the same time, with 
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stimulation by TFG-β, fibroblasts proliferate and synthesize new extracellular 
matrix (ECM) components (Kisseleva and Brenner 2008). In addition, some of 
the fibroblasts differentiate into myofibroblasts, characterized by de novo 
expression of α-smooth muscle actin (α-SMA) (Hinz 2007), which will 
provide wound contraction. Re-epithelialization is also part of the proliferation 
phase. This refers to the re-growth of keratinocytes and migration over the 
surface of the granulation tissue. Re-epithelialization may develop from the 
epidermis of wound edges, or from deep structures, such as hair follicle, sweat 
gland and sebaceous gland. 
 
1.2.3.3  Remodeling phase – scar formation.  
Once the re-epithelization process is completed, keratinocytes stratify and 
synthesize a new basement membrane. In the dermis, the majority of 
myofibroblasts, endothelial cells, macrophages undergo apoptosis and exit the 
scar. The fibroblasts slowly remodel the new ECM by producing more mature 
components that give strength to the scar (Mauch 1998; McAnulty 2007).  
 
Skin regulation for wound healing is limited. The new skin is devoid of skin 
appendages, and the scar consists of a dense fibrous dermis covered by an 
epidermis. If the inflammatory signals remain active, the balance of ECM 
synthesis and ECM degradation is impaired, which will lead to the formation 
of a hypertrophic scar. In severe burns, the wound healing mechanism may not 
be able to close the wound, in which case an autologous skin graft or cultured 





1.3.1 ABC transporters 
ATP-binding cassette (ABC) proteins, one of the largest families of active 
transport molecules (Higgins 1992; Dean, Rzhetsky et al. 2001), are abundant 
in the genomes of all organisms, and are involved in efflux of molecules from 
eukaryotic cells (Annilo, Chen et al. 2006). The ABC transporters transport 
substances from the cytoplasm or plasma membrane out of the cell, or 
transport substances into organelles such as the peroxisome, endoplasmic 
reticulum and lysosomes. Almost all ABC transporters are believed to efflux 
molecules by an energy-dependent process involving ATP binding and 
hydrolysis. In humans, ABC proteins consume cellular ATP to drive the 
transport of various substances across cell membranes, including drugs, 
metabolites and other compounds. To date, about 50 human ABC transporters 
have been identified in a variety of tissue and cells (Schinkel and Jonker 2003).  
 
The ABC transporters have a relatively conserved structure; consisting of two 
ABC domains and two transmembrane domains (TMDs) (Fig.1.3). These 4 
domains can be within one polypeptide chain (full transporters) or within two 
separate proteins (half-transporters). The ABC domains are the site of binding 
and/or hydrolysis of cytoplasmic ATP. The TMD domains contain polypeptide 
chains that cross the cytoplasmic membrane several times, normally forming 















Fig.1.3. The structure of ABCG2 transporter. The ATP binding cassette (ABC) 
proteins are present in all living species. The G subfamily of ABC transporter – 
ABCG2, contains ABC domains and transmembrane domains (TMD). The ABC 
domains are the sites to bind and hydrolyze ATP, while the TMD domains transport 




1.3.2 The structure and general functions of ABCG2 
The ABC transporters are divided into seven subfamilies (from A to G), based 
on the arrangement of sub domains. ABCG2 is the second member of the G 
subfamily of ABC transporters. ABCG2 was first cloned from human MCF-7 
breast cancer cells, and named as breast cancer resistance protein (BCRP) 
(Doyle, Yang et al. 1998). Soon after, other labs reported almost identical 
genes termed as placental ABC protein (ABCP) (Allikmets, Schriml et al. 
1998) and mitoxantrone resistance protein (MXR) (Miyake, Mickley et al. 
1999). After the cloning of BCRP, ABCP and MXR gene, the Human Genome 
Nomenclature Committee suggested that this transporter be renamed as 
ABCG2.  
 
The human ABCG2 gene maps to chromosome 4q22, spans over 66kb and 
consists of 16 exons and 15 introns. ABCG2 is a 72 KDa protein composed of 
655 amino acids. ABCG2 protein is a half-transporter, requiring dimerization 
to become functionally active (Rocchi, Khodjakov et al. 2000). ABCG2 was 
first found and described in drug-resistant cell lines, and to date it has been 
confirmed that ABCG2 functions as a high capacity drug transporter with 
wide substrate specificity. ABCG2 can transport large, hydrophobic, both 
positively and negatively charged molecules, including chemotherapy agents 
(Mitoxantrone, topetecan, flavopiridol and methotrexate), fluorescent dyes 
(Hoechst 33342),  and different toxic compounds (Zhou, Schuetz et al. 2001; 





1.3.3  ABCG2 and cancer  
ABCG2 expression is seen in most human tumors. Using the monoclonal 
antibody BXP-21, ABCG2 expression has been seen in 21 tumor types, with a 
high frequency in carcinomas of the digestive tract, endometrium, lung and 
melanoma (Diestra, Scheffer et al. 2002). In a large study of 149 AML cases, 
ABCG2 was reported to be a prognostic factor of complete remission, 4-year 
disease free survival and 4-year overall survival. In addition, ABCG2 was 
detected in lung, oesophageal cancers and glioma (Jin, Bin et al. 2009).   
 
ABCG2 may also contribute to cancer cell proliferation. An RNA interference 
study showed that the suppression of ABCG2 significantly inhibits cancer cell 
proliferation, and the blocking of ABCG2 transporter by fumitremorgin C 
inhibited cell proliferation via prolonged G0/G1 cell cycle interval (Chen, Liu 
et al.).  
 
ABCG2 may also serve as a novel marker for cancer stem cells (CSCs). “Side 
population”, or SP cells – which efficiently effluxed dye in FACS analysis - 
were suggested to be a novel approach to isolate CSCs, as this dye efflux 
capacity is enriched in normal stem cells. Several studies have shown that side 
population cell populations selected from different tumor cell lines and 
samples have higher tumorigenicity in immunodeficiency mice, and higher 
colony forming efficiency and proliferation capacity, when compared with 
non-SP cells. SP cells also show higher chemoresistance to conventional 
antitumor agents, such as doxorubicin and methotrexate, compared with non-
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SP cells (Hirschmann-Jax, Foster et al. 2004; Haraguchi, Utsunomiya et al. 
2006; Kruger, Kaplan et al. 2006).  
 
1.3.4 ABCG2 and stem cells  
The “side population” phenotype, i.e. the capacity to efficiently transport the 
fluorescent dye Hoechst 33342, has been identified as a universal 
characteristic of stem cells (Zhou, Schuetz et al. 2001; Kim, Turnquist et al. 
2002; Scharenberg, Harkey et al. 2002; Zhou, Morris et al. 2002; Martin, 
Meeson et al. 2004; Jonker, Freeman et al. 2005). These studies have shown 
that ABCG2 is responsible for the Hoechst 33342 dye efflux phenomenon and 
confers the “side population” phenotype both in the human and mouse model. 
Therefore, ABCG2 has been suggested as a possible universal marker for 
multiple stem cells. A number of studies have proven that ABCG2 is 
expressed in a wide range of tissues, including bone marrow, skeletal muscle, 
embryonic stem cells, hematopoietic stem cells, pancreas, lung, heart, testis, 
cornea, conjunctiva, limbal epithelium, brain, prostate and embryo (Zhou, 
Schuetz et al. 2001; Kim, Turnquist et al. 2002; Scharenberg, Harkey et al. 
2002; Martin, Meeson et al. 2004; Jonker, Freeman et al. 2005). Taken 
together, these findings indicate that ABCG2 expression is a conserved feature 
of stem cells from a wide variety of tissues, thus ABCG2 is a useful putative 
marker for identifying stem cells.  
 
On the other hand, does ABCG2 have a specific function in stem cells? High 
expression of ABCG2 was found in SP cells from hematopoietic sources as 
well as nonhematopoietic sources, such as muscle, pancreas, brain and 
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embryonic stem (ES) cells, which suggest that it is important for stem cells. It 
was shown that the efficiency of generating chimeric mice from ES cells 
increases when ES cells with the side population phenotype were used (Zhou, 
Schuetz et al. 2001). This result suggests that ABCG2 has a unique function in 
stem cells, and its role is to maintain progenitor cells in an undifferentiated 
state. This was further supported by a study of bone marrow transplantation 
(Zhou, Schuetz et al. 2001), in which transplantation of ABCG2-
overexpressing bone marrow cells into lethally irradiated mice resulted in a 
lower number of mature hematopoietic cells. This was interpreted as the 
increased efflux of substances required for differentiation, caused by ABCG2. 
Using ABCG2 knockout mice, it was confirmed that ABCG2 is the only 
contributor to the SP transport phenotype in hematopoietic cells (Zhou, Morris 
et al. 2002), and that ABCG2 protected hematopoietic stem cells against the 
toxicity of the chemotherapeutic drug mitxantrone.  
 
Later, it was found that ABCG2 enhances the survival of hematopoietic stem 
cells in hypoxia through its interactions with heme (Krishnamurthy, Ross et al. 
2004). This might explain why stem cells can thrive under low oxygen 
condition. ABCG2 binds haem and diminishes the cellular accumulation of 
porphyins. In ES cells, ABCG2 has also been shown to protect ES cells from 
porphyrin accumulation during colony formation (Susanto, Lin et al. 2008). 
ABCG2 is sharply down-regulated during the process of hematopoietic stem 
cell differentiation, and is expressed at a low level in mature cells, compared 
with progenitor cells (Scharenberg, Harkey et al. 2002). The same 
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phenomenon was observed in human neural, retinal and ES cells 
(Bhattacharya, Das et al. 2007; Apati, Orban et al. 2008).  
 
There is also evidence that ABCG2 is involved in the regulation of stem cell 
differentiation. When ABCG2 is overexpressed in retinal progenitor cells by 
retrovirus-mediated transduction, differentiation is blocked, accompanied by 
an increase of stem cell markers and the SP cell phenotype. In contrast, 
siRNA-mediated silencing of ABCG2 expression in retinal progenitor cells 
depletes the SP cell population and promotes differentiation (Bhattacharya, 
Das et al. 2007).  
 
Taken together, it was hypothesized that ABCG2 might function as a general 
protectant against endogenous and exogenous substances, expelling substrates 
that induce lineage differentiation, thereby blocking stem cell differentiation, 
and increasing stem cell survival and proliferation potential.   
 
1.4 AIM AND OUTLINE OF THESIS 
The aim of this thesis is to improve the cultivation and characterization of 
human epidermal stem cells. First, after mastering the basic techniques of 
culturing keratinocytes using Green’s FAD medium with a mouse 3T3-J2 
feeder cell layer, and understanding the clinical need for a serum-free culture 
system, a novel serum-free and feeder-free culture system was successfully 
developed (Chapter 2). Second, in the process of micro-dissecting human hair 
follicles, a population of clonogenic cells was identified, which led to a study 
of human hair follicle sheath-derived mesenchymal stem cells (Chapter 3). 
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The major part of this thesis then concentrates on the hypothesis that the 
ABCG2 transporter can identify human epidermal stem cells in interfollicular 
epidermis (Chapter 4), and that ABCG2 function contributes to the regulation 
of self-renewal, proliferation and differentiation of human epidermal stem 
cells, as is clearly shown by the use of a transplantation model (Chapter 5).  
The thesis concludes (Chapter 6) with a general discussion on potential value 












Development of a novel chemically defined medium  








2.1  SUMMARY 
 
Human skin keratinocytes are routinely expanded on 3T3 mouse fibroblast 
feeder layer in a medium containing fetal bovine serum and EGF. This culture 
system has been widely used for the preparation of cultured epithelial 
autografts, to treat severe burns patient, vitiligo and other skin defects. 
However, this culture system relies on 3T3 mouse feeder cells and foetal 
bovine serum, which carries the potential risk of exposing human cells to 
animal pathogenic or immunogenic agents. There is a need to develop efficient 
serum-free and feeder-free culture systems which can eliminate the above 
risks without reducing the cell yield. A novel keratinocyte culture system was 
therefore developed to meet these demands. Here we demonstrate that human 
primary keratinocytes can be efficiently established and serially expanded 
using this novel culture system. Keratinocyte clones can be expanded with 
cells maintaining their undifferentiated phenotype, and the keratinocytes can 
be serially cultivated for more than 10 passages. Furthermore, keratinocytes 
maintained in this culture medium can be induced to differentiate into a fully 
stratified skin-equivalent epidermis in vitro. Thus the findings presented here 
support the use of this novel defined culture medium as an alternative to 
classic culture medium containing fetal bovine serum and mouse feeder cells, 





2.2  INTRODUCTION 
 
In 1975, Rheinwald and Green set up the first serial cultivation method for 
human keratinocytes using a γ-irradiated 3T3 feeder cell layer and foetal 
bovine serum(Rheinwald and Green 1975). This method was successfully 
applied to the propagation of human embryonic stem (ES) cells in 1998 using 
mouse embryonic feeder (MEF)(Thomson, Itskovitz-Eldor et al. 1998). The 
successful propagation of keratinocytes led to the clinical therapeutics of 
regenerating skin and cornea (Ronfard, Rives et al. 2000; Pellegrini, De Luca 
et al. 2007), which marked the beginnings of regenerative medicine. However, 
this culture system relies on a mouse-derived feeder cell layer and the addition 
of foetal bovine serum to the culture medium. Using murine feeders carries the 
risk of exposing cell culture to animal pathogens and even of introducing 
immunogenic agents, such as N-glycolylneuraminic acid (Neu5Ac)(Martin, 
Muotri et al. 2005). Foetal bovine serum shows batch-to-batch variation in 
terms of biological properties, its components are not fully defined, and there 
is a lot of paperwork and analysis needed to monitor serum quality. 
 
Since the first serum-free medium was developed by Boyce and Ham in 
1983(Boyce and Ham 1983), several serum-free and feeder-free keratinocyte 





 epithelial medium and VN-GF medium (Boyce and Ham 
1983; Wang, Chen et al. 1995; Hollier, Harkin et al. 2005; Dawson, Upton et 
al. 2006) etc. These products have been shown to support keratinocyte growth 
without a feeder layer, and also to provide valuable models for studying 
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keratinocyte-fibroblast interactions and keratinocyte signal transduction 
pathways. However these media still require undefined products, such as 
bovine pituitary extract (BPE) or human serum albumin, or large quantities of 
added growth factors; cells grown using these media require high cell-seeding 
densities and cells can only be sub-cultured for a few passages. The clonal 
growth and keratinocyte stem cell preservation was observed to be poor in 
these media formulations (Sun, Higham et al. 2004). To date, there is no 
serum-free, feeder-free and fully defined medium which can clonogenically 
propagate epidermal cells as effectively as the original Rheinwald & Green 
protocol (Pellegrini, De Luca et al. 2007).  
 
Previous studies have shown that extracellular matrix components, such as 
fibronectin, laminin, collagen and vitronectin could support the attachment, 
migration and proliferation of keratinocytes (Woodley, Wynn et al. 1990; 
Pouliot, Saunders et al. 2002). In combination with growth factors and 
mitogens, extracellular matrix has been successfully used to develop serum-
free and feeder-free culture media for propagating human keratinocyte and ES 
cells (Ludwig, Levenstein et al. 2006; Richards, Leavesley et al. 2008). In 
addition, it was demonstrated that 3T3 feeder layer cells supported self-
renewal and expansion of keratinocytes by secreting large quantities of IGFs 
and ECM proteins (Ainscough, Barnard et al. 2006). Based on these recent 
findings, we developed a novel chemically-defined, serum-free and feeder-free 
culture system, including growth factors, mitogens and extracellular matrix. 
We showed that human keratinocytes can be successfully cultivated and 
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serially propagated in this novel culture medium, and keratinocytes have 
shown clonal growth and preservation of features of stemness in this medium.  
  
2.3  MATERIALS AND METHODS 
 
2.3.1  Isolation of keratinocytes from human skin 
Discarded human healthy skin samples were obtained from patients 
undergoing plastic surgery operations, with informed consent and ethics 
committee approval from our Singhealth Institution. Six skin samples were 
used in this study. Human skin samples were washed in phosphate-buffered 
saline (PBS) containing gentamicin and incubated in 0.25% Dispase II (Roche, 
Singapore) overnight at 4 
0
C. The next day, epidermis was peeled away from 
the dermis with fine forceps, minced and incubated in 0.05% trypsin-0.02% 
EDTA (Gibco, Invitrogen, Singapore) at 37 
0
C for 15 minutes. Keratinocytes 
from the epidermis were collected and suspended in PBS and filtered on a 
70µm filter (Falcon, Becton Dickinson, Singapore) to get a single cell 
suspension before cell counting and seeding.  
 
2.3.2  Cultivation of keratinocytes on a 3T3 feeder cell layer using cFAD 
medium 




 on a 
lethally -irradiated 3T3-J2 feeder layers as previously described [33]. The 
keratinocytes were cultured at 37
0
C in 5% CO2 humidified atmosphere. The 
cFAD culture medium (Rheinwald and Green 1975) was a mixture of 
Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Invitrogen, Singapore) 
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and Ham’s F12 (Gibco, Invitrogen, Singapore) at a ratio of 3:1, containing 
10% foetal bovine serum (Hyclone, Logan, UT, USA), insulin (5 g/ml), 
adenine (0.18 mM), hydrocortisone (0.4 g/ml), cholera toxin (0.1 nM), 
triiodothyronine (2 nM), epidermal growth factor (10 ng/ml), L-glutamine (4 
mM) and penicillin-streptomycin (50 IU/ml). The culture medium was 
changed every 3 days, and cultures were passaged at sub-confluence and 




. Keratinocytes were serially 
cultivated as above.  
 
2.3.3 Cultivation of keratinocytes using NB medium 
The new formulation described here is referred to as NB medium. NB medium 
is a mixture of DMEM and Ham’s F12 at a ratio of 1:1, containing insulin (5 
g/ml), adenine (0.18 mM), hydrocortisone (0.4 g/ml), cholera toxin (0.1 
nM), triiodothyronine (2 nM), epidermal growth factor (10 ng/ml), B-27 
(X100), L-glutamine (2 mM) and penicillin-streptomycin (50 IU/ml). The 
culture plates were coated with 2 µg/ml fibronection (Invitrogen) at 4
0
C 
overnight and used the next day. Human primary keratinocytes were isolated 




onto pre-coated petri-dish in NB 
medium; and cultured at 37 
0
C in 5% CO2 and humidified atmosphere, the 
medium was changed every 3 days until cells reach 80-90% confluence. 






2.3.4  Colony forming efficiency (CFE) assay 
To evaluate and compare CFE of keratinocyte maintained in different culture 
medium, 100 cells from each culture at different passages were seeded onto 10 
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cm petri-dish containing irradiated 3T3 feeder layer, and they were allowed to 
grow for 12 days. The culture medium was changed every 4 days. At the end 
of culture period, the culture was fixed with formalin and stained with 1% 
Rhodamine B. The CFE was calculated and expressed as a percentage of the 
number of plating cells.  
 
2.3.5  Immunofluorescence staining 
Immunofluorescence staining was performed by a method previously 
described [30]. In brief, keratinocyte cultures on coverslips were fixed with 
4% paraformaldehyde at 4°C for 15 minutes, after blocking with 5% goat 
serum in PBS for 30 minutes. Primary antibody was applied in PBS at room 
temperature for 1 hour. After washing with PBS three times, Alexafluor-488 
conjugated secondary antibody (1:200, Gibco, Invitrogen, Singapore) was 
applied for 1 hour in a dark chamber. After washing with PBS three times, the 
slides were mounted with Vectashield fluorescent mounting medium 
containing 4'-6-diamidino-2-phenylindole (DAPI, Burlingame, CA, USA) and 
covered with cover slips. The slides were visualized and photographed with a 
fluorescent microscope (Axiovert 200, Carl Zeiss, Singapore). The following 
primary antibodies were used: anti-human antibodies against α6-integrin 
(Clone: GoH3), β1-integrin (clone: 4B7R), CD71 (clone: C2), keratin 14 
(clone: RCK107, all from BD Biosciences, Mountain View, CA, USA), p63 






2.3.6  Flow cytometry analysis 
Human keratinocytes maintained in different media were dissociated with 
trypsin (0.05%) and were suspended at a concentration of 10
6
 cells/ml in 
staining medium (DMEM containing 2% FBS and 10 mM HEPES), incubated 
with primary antibody for 30 minutes on ice, washed with PBS containing 1% 
FBS, then incubated with Alexafluor-488 conjugated rabbit anti-mouse 
secondary antibody (1:200, Gibco, Invitrogen, Singapore) for 30 minutes, 
washed with PBS/1% FBS 5 minutes for three times, and resuspended in 
staining medium. The cells were kept on ice until flow cytometry analysis was 
performed. Fluorescence-activated cell sorting (FACS) was performed at 
National University Medical Institute (NUMI, Singapore) with a 
FACSVantage SE (BD Biosciences, Mountain View, CA) cell sorter. The 
following primary antibodies were used: anti-human antibodies against α6-
integrin, β1-integrin, CD71, cytokeratin 14 (all from BD Biosciences, 
Mountain View, CA, USA), p63 and involucrin ( Santa Cruz, CA, USA). 
 
2.3.7  Karyotyping analysis of keratinocytes 
Karyotype analysis of keratinocytes was performed at the Cytogenetics lab, 
Department of Pathology, Singapore General Hospital. The cells cultivated in 
the 3T3 system and in NB medium were treated with colcemid, lysed, and 
fixed in methanol-acetic acid. The cell chromosomes were stained with Wright 





2.3.8  Organotypic culture 
Glycerol-preserved allogeneic skin (GPA, EURO SKIN BANK, EA 
Beverwijk, Netherland) was used and washed in PBS containing penicillin-
streptomycin (50 IU/ml). The epidermis was removed mechanically after 3 
cycles of snap-freezing and thawing. The de-epidermalized dermis (DED) was 
cut into 2 x 2 cm squares, and a 1 cm diameter stainless steel ring was placed 
on the reticular side of each dermis square. Human dermal fibroblasts were 
seeded at 2 x 10
5
 cells per ring and grown for 1 day. Then the keratinocytes 
cultured in cFAD or NB medium were plated at 2 x 10
5
 cells per ring 
respectively, allow to grown for four days to reach a confluent monolayer. 
Then the cultures were lifted and cultured at the air-liquid interface for 3 
weeks. The cultures were embedded, snap frozen in liquid nitrogen; frozen 
sections were cut at 5 μm and stained with haematoxylin and eosin.  
 
2.4  RESULTS  
 
2.4.1  NB medium supports keratinocytes growth 
Before testing the culture media, several extracellular matrix components were 
tested for their ability to support keratinocyte culture: collagen type I, collagen 
IV, gelatin, fibronectin, laminin and Matrigel. Among them, fibronectin 
consistently supported human keratinocyte growth (Table 2.1). The presence 
of collagen IV together with fibronectin further improved the survival of 
human keratinocytes (Table 2.1). To define the minimal requirement for 
human keratinocyte growth with cost consideration in mind, fibronectin alone 
was used as the matrix in the experiments described below to define the final 
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Table 2.1. Summary of keratinocyte growth on different coating matrix.  The human 
keratinocytes were cultured onto different coating matrix: collagen I, collagen IV, 
gelatin, fibroniectin, laminin and matrigel. The relative amounts of cells after 1 
passage are indicated as X symbols. The collagen IV, fibronectin and matrigel 
consistently supported keratinocytes growth, while collagen I, gelatin and laminin 




To determine whether keratinocytes can be maintained in NB medium, a 
variety of tests were used. Human primary keratinocytes could be propagated 
in NB medium, where cells formed large and condensed colonies composed of 
cells with a small diameter, which appeared very similar in morphology to 
those cells grown in cFAD medium (Fig.2.1). Furthermore, these cells could 
be maintained with this undifferentiated morphology for up to 8 to 10 passages 
in NB medium. In contrast, keratinocytes cultured and maintained in a 
commercial serum-free medium (KSFM) could only be propagated for 4 to 6 
passages, and the cells showed sparse growth, with larger, more dysplastic 
morphology, which typically represents a more differentiated cell phenotype .   
Fig 2.1 Cell culture of keratinocytes in cFAD medium and NB medium. Human skin 
keratinocytes were isolated from skin biopsies and plated onto 3T3 feeder (50,000 
cells/cm
2
, Fig.2.1.A, Fig.2.1.B) in cFAD medium or cultured in NB medium without 
feeders  (Fig.2.1.C, Fig.2.1.D). After seeding for 5-7 days, keratinocytes formed big 
circular colonies on 3T3 feeders in cFAD medium, consisting of 30-40 cells. In NB 
medium, similar sized colonies were also formed. Both keratinocytes in cFAD 
medium and in NB medium reached confluence within 9-10 days (Fig.2.1.B, 
Fig.2.1.D), but surprisingly, the keratinocytes in NB medium show homogenous and 
small cell size (Fig.2.1.D). 
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2.4.2 Keratinocytes cultured in NB medium maintained their colony 
forming capacity 
Next, the colony forming capacities of keratinocytes maintained in different 
culture medium formulations were studied and compared. To analyze the 
colony forming efficiency (CFE), keratinocytes from each culture were seeded 
at a density of 100 cells per 10cm petri-dish, which was pre-seeded with 
lethally irradiated 3T3 feeder layer, and allowed to grow for 12 days. As 
shown in Figure 2.2, the CFE value for cFAD medium and NB medium were 
27% ± 1.8% and 22% ± 2.3% respectively. No difference in CFE was found 
between cells grown in cFAD medium and NB medium (Fig. 2.2, p > .05, n 
=5). Thus the colony forming capacity of keratinocytes was maintained in NB 







       
          
Fig.2.2 Colony forming efficiency assay of keratinocytes in NB medium and cFAD 
medium. To analyze the CFE, keratinocytes from cFAD and NB cultures were 
harvested, and seeded at a density of 200 cells per 100mm petri-dish, which was pre-
seeded with mitomicin C treated 3T3 feeder layer, and this culture was allowed to 
grow for 12 days. As shown in Figure 2.2, after cultured for 12 days, keratinocytes 
showed similar CFE and colony size compared to cells maintained in cFAD medium. 
The CFE value for cells grown in cFAD and NB medium were 14% ± 0.4% and 18% 
± 1.1% respectively, and there is no significant differences in colony forming 
efficiency (p > 0.05) between two cultures.  
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2.4.3 Keratinocytes cultured in NB medium maintain a stem cell 
phenotype 
Human keratinocytes express putative epidermal stem cell markers that 
distinguish them from differentiated cells. To investigate whether 
keratinocytes grown in NB medium remain undifferentiated, the phenotypes of 
these cells were characterized using immunofluorescence staining and flow 
cytometry analysis. The keratinocytes maintained in NB medium expressed 
high levels of α6-integrin, β1-integrin, keratin 14 and p63, whist expressing 
low levels of CD71 and involucrin (Fig.2.3). The flow analysis data confirmed 
these immunofluorescence staining results. Taken together, these studies 
indicated that the keratinocytes grown in NB medium can be established and 
serially propagated while maintaining their expression of epidermal stem cells 








Fig.2.3 Flow cytometric analysis of keratinocytes phenotype in NB medium. 
Keratinocytes grown in NB medium for 6 passages were harvested, and incubated 
with following antibodies: α6-integrin, β1-integrin, keratin 14, p63, CD71 and 
involucrin (blank line); isotype controls are shown by the red line. As shown in Fig 
2.3, the keratinocytes maintained in NB medium expressed high levels of α6-integrin, 
β1-integrin, keratin 14 and p63, while expressed low level of CD71 and involucrin. 
This implied that keratinocytes cultured in NB medium were being maintained in an 
undifferentiated state.   
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2.4.4  Keratinocytes cultured in NB medium can form stratified 
epidermis  
Next, it was investigated that whether keratinocytes grown in NB medium can 
form confluent and stratified epithelial sheet. Human skin keratinocytes grown 
in NB medium were plated onto 100mm petri-dish at a density of 10,000 
cells/cm
2
 and allowed to grow for 7-9 days. The keratinocyte culture was 
treated with 0.25% Dispase II for 20 minutes at 37°C. As shown in Fig 2.4, a 
typical stratified epithelial sheet was formed in the petri-dish, and the whole 
epithelial sheet shrunk upon Dispase treatment in a normal way. 
 
 
                                
Fig.2.4 Keratinocytes grown in NB medium form a confluent epithelial sheet. Human 
skin keratinocytes grown in NB medium were plated onto 100mm petri-dish at a 
density of 10,000 cells/cm
2
 and allowed to grown for 7-9 days. The keratinocyte 
culture was then treated with 0.25% Dispase II for 20 minutes at 37°C. As shown 
above, a typical stratified epithelial sheet was formed in the petri-dish, and the whole 
epithelial sheet was observed to shrink upon treatment with Dispase.     
49 
 
2.4.5 Karyotyping of Keratinocytes cultured in NB medium  
Keratinocytes cultured in vitro can acquire genetic alteration through 
passaging, as they are being subjected to severe selection pressure outside 
their normal environment. To examine the genetic stability of keratinocytes in 
NB medium, the karyotypes of keratinocytes were examined after continuous 
culture in NB medium over 4 and 12 passages (1-3 months). As shown in Fig 
2.5, the karyotype was observed to be normal at each keratinocyte passage 
(Fig.2.5). No major translocations or other chromosomal changes were found 
during this extended culture period. Therefore, human keratinocytes cultured 
in NB medium maintain their genomic stability and integrity.  
 
 
Fig.2.5. Karyotyping analysis of keratinocytes grown in NB medium. To examine the 
genetic stability of keratinocytes in NB medium, karyotyping of keratinocytes was 
carried out after they had been cultured in NB medium for 4-12 passages (1-3 
months). The keratinocytes in both passage 4 and passage 12 showed normal 
karyotyping, no obvious translocations or chromosomal changes were present.  
  
Passage 4                                              Passage 12 
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2.4.6 Keratinocytes cultured in NB medium can form stratified 
epidermis in organotypic culture 
Having confirmed that keratinocytes could be expanded in NB cultured 
medium, the keratinocytes maintained in this medium were then examined for 
their ability to reconstitute a stratified epidermis. The de-epidermalized dermis 
(DED) was  prepared by snap-freezing and thawing of glycerol-preserved 
allogenic skin . Keratinocytes cultured in NB medium or with 3T3 feeders 
were seeded onto this DED dermal substitute and induced to differentiate by 
lifting cultures to air-liquid interface. In a 3 week culture period, both cultured 
cell groups developed a fully stratified epidermis, consisting of a stratum 
basale, stratum spinosum and stratum granulosum (Fig.2.6). The overall 
structure of both stratified epidermal examples was similar to one another, 
similar to that of normal human skin (Fig 2.6).   
 
Fig.2.6 Organotypic cultures of keratinocytes on a type I collagen gel. Keratinocytes 
grown in NB medium were seeded onto type I collagen gel and was grown for 14 
days. The keratinocytes formed a pluristratified epidermis, typical of a normal 
epidermal structure and cellular differentiation: a basal layer with keratinocytes 
oriented perpendicularly to the underlying collagen gel, three to four layers of spinous 
cells, three to four layers of granular cells characterized by the presence of 
keratohyalin granules, and anucleated, flattened cornified cells forming a compact 
stratum corneum. Such structure was also observed from keratinocytes grown in 





2.4.7 Immunofluorescence staining of keratinocytes in organotypic 
culture  
To examine the status of keratinocytes grown in organ culture, 
immunofluorescence staining of proliferation, differentiation and epithelial 
markers were performed. As shown in Figure 2.7, most of basal epithelial cells 
in organ culture were strongly stained with keratin 14 , a basal epithelial cell 
marker. The positively stained cells were estimated to occupy about 80-90% 
of the cultured cells. The staining of α6-integrin, showed a similar pattern in 
basal layer. p63 showed sparse positive staining in the basal layer, while the 
differentiation protein involucrin showed positive staining in the stratum 
corneum. Interestingly, no significant difference of immune staining was 
observed between cFAD and NB group.  These data implies that keratinocyte 
organ culture from cFAD and NB medium showed similar expression of 
putative epithelial stem cell markers, while expressed low level of 












Fig. 2.7 Immuofluorescent staining of keratinocyte organ culture. In the NB group, 
most of basal epithelial cells were strongly stained with cytokeratin 14 (green), a 
basal epithelial cell marker. The positively stained cells were estimated to occupy 
about 80-90% of the cultured cells. The staining of α6-integrin, a basal epithelial stem 
cell marker (as a component of hemidesmosomes), showed a similar pattern in basal 
layer. p63 showed sparse positive staining in the basal layer, while the differentiation 
protein involucrin showed positive staining in the stratum corneum. Interestingly, no 




2.5  DISCUSSION 
 
In 1975, Rheinwald and Green set up the 3T3 feeder cell based culture system, 
the first serial cultivation method for skin keratinocytes(Rheinwald and Green 
1975). This protocol employed mouse 3T3 fibroblasts as a feeder layer, which 
selectively support keratinocyte expansion and inhibit skin fibroblast growth; 
the culture medium was supplemented with foetal bovine serum and growth 
factors. In the 3T3 culture method, keratinocytes can be expanded over a long 
term, and keratinocyte stem cells (defined as holoclone-forming cells in 3T3 
culture) and clonal growth was well maintained in this method. To prepare 
feeders, 3T3 fibroblasts have to be simultaneously and constantly maintained 
with keratinocyte culture, and 3T3 cell proliferation has to be stopped by 
exposing the cells to -irradiation or anticancer drugs. Thus, the maintenance 
of 3T3 cells is both labour-intensive and costly.    
 
The other classical keratinocyte culture method is the Boyce-Ham method, 
which was developed in 1983(Boyce and Ham 1983). This involves a low 
calcium culture medium based on the MCDB153 medium, avoiding the use of 
foetal bovine serum, but supplemented with several growth factors and bovine 
pituitary extract (BPE). As there is a great concern with bovine spongiform 
encephalopathy and Creutzfeldt-Jakob disease, BPE was later replaced by 
various human recombinant growth factor cocktails. The Boyce-Ham method 
does not require any special cell culture techniques or feeder cells, and it has 
already been marketed in the form of a keratinocyte culture kit by certain 
commercial companies. However, keratinocytes can only be maintained in this 
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serum free medium for a few passages, and the potential of the cultured 
epithelium prepared using Boyce-Ham method is not as high as the ones 
prepared by Rheinwald-Green method.  
 
The identification of all exogenous signals required for human keratinocyte 
expansion is important for clinical application and stem cell biology studies of 
keratinocytes. Since the development of the Boyce-Ham method in 
1983(Boyce and Ham 1983), several serum-free and feeder-free keratinocyte 





 keratinocyte medium and VN-GF medium (Boyce and 
Ham 1983; Wang, Chen et al. 1995; Hollier, Harkin et al. 2005; Dawson, 
Upton et al. 2006) etc. These products have been shown to support 
keratinocyte growth without foetal bovine serum or a 3T3 feeder layer; 
moreover, they provide a valuable model for studying keratinocyte-fibroblast 
interactions and keratinocyte signal transduction pathways. However as 
discussed above, these media still require undefined or semi-defined 
components and products, such as bovine pituitary extract (BPE) or human 
serum albumin, or large quantities of growth factors. Cells grown using these 
media require high cell-seeding densities, and cells can only be subculture for 
a few passages before they senesce or differentiate. Moreover, clonal growth 
and retention of keratinocyte stem cell characteristics was observed to be very 
poor in these media (Sun, Higham et al. 2004). To date, therefore, there is no 
serum-free, feeder-free and fully defined medium which can support 




Observing the progress in the field towards semi-defined media formulations, 
it was apparent that more success was being generated in the embryonic stem 
cell arena (Ludwig, Levenstein et al. 2006; Chen, Gulbranson et al. 2011). By 
omitting foetal bovine serum, and using a combination of growth factors, 
small molecules and extracellular matrix components, less differentiated ES 
cells and iPS cells were being maintained in such media for a longer duration, 
and even germline transmission was apparently not compromised (Xu, 
Inokuma et al. 2001; Wang, Zhang et al. 2005; Chen, Gulbranson et al. 2011). 
Given the similarities between the culture methods used for epithelial cells and 
ES cells, and in light of progress in developing tolerated serum-free and 
feeder-free culture strategies for pluripotent stem cells, we hypothesized that 
an ES-developed strategy could be effectively applied to keratinocyte culture. 
The results presented here show that this does indeed appear to be the case. 
 
When using the novel keratinocyte culture medium described here, fibronectin 
was used to replace the effect of 3T3 feeder layer in Rheinwald and Green’s 
protocol. In previous studies, several extracellular matrix was used to enhance 
keratinocyte attachment and proliferation, the results seems confusing and 
contradictory (Kubo, Kan et al. 1987; Woodley, Wynn et al. 1990; Dawson, 
Goberdhan et al. 1996; Pouliot, Saunders et al. 2002; Richards, Leavesley et 
al. 2008). It appears that  different concentrations of extracellular matrix, 
different cell seeding density and different culture medium used can all 
influence keratinocyte proliferation. In this study, different extracellular 
matrix components were compared (Tab 3.1), and the fastest keratinocyte 
growth was observed on fibronectin- and Matrigel-coated substrate in this 
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serum free medium used. Matrigel is an extract from mouse tumor tissue rich 
in basement membrane proteins, and it also contains several growth factors 
(Hynes 1992). To prepare a chemically defined medium, and to exclude the 
effect of unknown factors, fibronectin was therefore selected for this study.  
  
B27 was used to replace the fetal bovine serum. B27 was first used for culture 
of hippocampal neurons, and neurons from embryonic rat striatum, the 
substantia nigra, the subiculum, the cerebral cortex, the postnatal dentate 
granule, the cerebellum, and the dentate gyrus in serum-free conditions 
(Brewer 1995). B27 contains vitamins like biotin, DL-alpha-tocopherol, and 
DL-alpha-tocopherol acetate. It also contains catalase, human recombinant 
insulin, superoxide dismutase proteins, and other components such as 
corticosterone, D-galactose, ethanolamine hydrochloride, reduced glutathione, 
linoleic acid, linolenic acid, triiodo-L-thyronine. It has been reported that ES 
cells can be maintained in medium containing N2/B27 (Yao, Chen et al. 
2006), and corneal epithelial cells and corneal endothelial precursor cells 
proliferate actively in B27-containing medium with no foetal bovine serum or 
feeder cells (Yokoo, Yamagami et al. 2005; Yokoo, Yamagami et al. 2008). 
The study of the signaling pathways of corneal epithelia cells maintained in 
B27-supplemented serum-free medium suggested that B27 might activate 
multiple signaling pathways in corneal epithelial cells, including WNT, 
PI3K/AKT and NFkB pathway, thereby helping to maintain cells in a 
proliferative state (Krishnan, Lakshmanan et al. 2010). For skin keratinocyte 
culture, B27 play similar role in maintaining cell proliferation. But further 




Our hypothesis has been validated by the experiments described here. It is 
clearly shown that human primary keratinocytes can be established and 
serially expanded using this novel culture system. Keratinocyte colonies can 
be expanded from single cells in this culture medium, and the cells maintain 
their undifferentiated phenotype and can be serially cultivated for more than 
10 passages. In addition, keratinocytes maintained in this culture medium can 
be induced to differentiate into a fully stratified skin-equivalent epidermis in 
vitro. This study has shown that this novel defined culture medium is a good 
alternative to the classic Rheinwald and Green culture protocol containing 
foetal bovine serum and mouse feeder cells. This holds great potential for 















3.1  SUMMARY 
Hair follicles contain discrete populations of mesenchymal and epithelial cells. 
In the hair follicle, the dermal papilla and hair follicle sheath cells have been 
shown to have powerful hair inductive properties (Gharzi, Reynolds et al. 
2003; Richardson, Arnott et al. 2005), but the stem cell properties of the hair 
follicle sheath have largely been overlooked. In this project, we isolated 
fibroblast-like cells from human hair follicle sheath. These cells showed 
extensive proliferative capacity and colony forming ability in culture. They 
also display a phenotype which is similar to that of bone marrow 
mesenchymal stem cells, and indeed can be successfully differentiated into 
adipocytes, chondrocytes and osteoblasts. Furthermore, these cells showed 
high telomerase activity, which is not observed in bone marrow mesenchymal 
stem cells. The identification and characterization of these hair follicle sheath 
derived mesenchymal stem cells will provide a novel alternative source to 
human bone marrow derived mesenchymal stem cells, and these cells have 
great potential in stem cell therapy and tissue engineering. 
 
3.2    INTRODUCTION 
Mesenchymal stem cells (MSCs) are clonal, multipotent and plastic-adherent 
stem cells that are typically
 
obtained from bone marrow, but they can also be 
isolated from
 
several other tissues such as umbilical cord blood and adipose
 
tissue (Pittenger, Mackay et al. 1999). MSCs have been shown to be capable 
of forming osteoblasts, chrondrocytes and adipocytes both in vitro and in vivo. 
Human MSCs are currently used in cell therapy and tissue engineering 





of ongoing clinical trials involving human MSCs to treat diseases such 
as myocardial infarction, graft-versus-host
 
disease, and to promote 
engraftment of bone marrow transplants (Koc, Gerson et al. 2000; Horwitz, 
Gordon et al. 2002; Koc, Day et al. 2002; Chapel, Bertho et al. 2003; Barry 
and Murphy 2004; Zhao, Liao et al. 2004). MSCs are attractive candidates for 
clinical use because of their
 
ease of isolation, their extensive proliferation and 
differentiation
 
capacity, and their hypoimmunogenic nature (Zhao, Liao et al. 
2004). 
 
So far, the most common source of MSCs has been the bone marrow (BM), 
although aspiration of bone marrow from patients is a highly invasive 
procedure. In addition, it has been demonstrated that the growth and the 
differentiation potential of bone marrow derived MSCs are limited (Barry and 
Murphy 2004). Thus, identification and characterization of alternative new 
sources of MSCs is of great importance. 
 
Mesenchymal stem cells in rodent hair follicles have been identified recently. 
Rat hair follicle-derived dermal stem cells have been isolated (Hoogduijn, 
Gorjup et al. 2006), and these cells showed a fibroblastic morphology in 
serum-containing culture medium, and were CD44+, CD73+, and CD90+. 
Following exposure to an appropriate induction medium, these cells exhibited 
the capacity to differentiate into various mesenchymal cell lineages, such as 
osteoblasts, adipocytes, chondrocytes and myocytes. In addition, 
multipotential stem cells were successfully isolated from neonatal murine 
dermis by a sequence of differential centrifugation and selective culture 
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conditions (Crigler, Kazhanie et al. 2007). In this project, human rather than 
mouse source was used to isolate and characterize the hair follicle sheath 
derived MSCs.    
 
3.3 MATERIALS AND METHODS 
3.3.1  Isolation, cultivation of hair follicle sheath (HFS) cells from 
human hair follicle 
Human hair follicle were micro-dissected and isolated from human scalp 
tissue (from hair transplantation procedures) under an inverted microscope, 
hair follicles were treated with 0.1% collagenase-Dispase at 37
o
C for 30 
minutes, and hair follicle sheaths were separated from hair follicle shafts. The 
sheaths (HFS) were minced and digested with 0.05% trypsin and 0.02% 
EDTA at 37
 o
C for another 30 minutes. HFS cells were collected and seeded at 
density of 50,000 cells per 10cm cell culture dish, with DMEM/F12 medium 
(1:1), supplemented with 10% fetal bovine serum.  
 
For long term culture, cells were trypsinized and subcultured at 50,000 cells 
per 10cm dish. For single cell culture, primary culture HFS cells were 
suspended at 50 cells/ml, single cell wax picked and seeded into a 24 well 
plate. After culturing for 7 days, homogeneous-looking colonies were 
collected and propagated.  
 
3.3.2 Flow cytometry analysis 
Freshly isolated, cultivated human HFS-MSCs and BM-MSCs (from 
STEMCELL
TM
 TECHNOLOGIES) were characterized with flow cytometry 
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analysis for cell surface phenotype. Cells were then trypsinized, collected and 
washed twice with PBS, suspended at a density of 1 million/ml in PBS, 
stained with fluorescein isothiocyanate (FITC) or phycoerythrin (PE) -
conjugated monoclonal antibodies for 15 minutes at room temperature. The 
cell surface markers used included CD34, CD45, CD38, CD14, CD24, CD29, 
CD31, CD44, CD49d, CD49e, CD49f, CDw90, CD105. Control cells were 
stained with corresponding immunoglobulin isotype controls as well.  
 
3.3.3  Colony forming efficiency (CFE) assay 
The colony-forming efficiencies of the HFS-MSCs and BM-MSCs were 
determined. HFS-MSCs and BM-MSCs at different passages were diluted and 
100 cells were seeded onto 100mm petri-dishes. After culturing for 12 days, 
the cell cultures were fixed with 3.7% formalin for 30 minutes at room 
temperature, and stained with 2% crystal violet. The colony number was 
counted and CFE scored.  
 
3.3.4  Induction of osteogenic, chondrogenic and adipogenic 
differentiation 
In vitro differentiation of HFS-MSCs into mesenchymal cells were induced by 
using  the following induction formulae: (1) adipogenic differentiation 
medium: DMEM supplemented with 10% FBS, 0.5 mM isobutyl-
methylxanthine, 1 μM dexamethasone, 10 μM insulin, and 200 μM 
indomethacin; (2) osteogenic medium: DMEM supplemented with 10% FBS, 
0.1 μM dexamethasone, 50 μM ascorbate-2-phosphate, and 10 mM β-
glycerolphosphate; (3) chondrogenic medium: DMEM supplemented with 1% 
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FBS, 6.25 μg/ml insulin, 10 ng/ml TGF-β1 and 50 nM ascorbate-2-phosphate. 






3.3.5 RT-PCR analysis of HFS-MSC differentiaton 
Expression of differentiation markers for each lineage was analyzed with RT-
PCR. Cultivated and differentiated HFS-MSCs and BM-MSCs were 
harvested, 1 g of total RNA was isolated using RNeasy kit, cDNA was 
synthesized using SuperScript III first-strand synthesis system. PCR primer 
sequences were designed using the primerQuest program of IDT, and 
expression of each lineage marker was compared between HFS-MSCs and 
BM-MSCs.  
 
3.3.6 Telomerase activity assay 
HFS-MSCs were collected, washed once in phosphate buffered saline, 
centrifuged (2,300 g × 5 minutes at 4
 o
C); the cell pellet was suspended in 200 
μl lysis reagent and left on ice for 30 minutes. Cell lysates were centrifuged 
(10,000 g × 20 minutes at 4
 o
C) and the supernatant extracts were aliquoted. 
Serial dilutions of protein extract of HFS-MSC corresponding to 10, 100, 500, 
1,000 and 5,000 cells, the protein extracts were subjected to PCR. Two 
microliters of PCR product were evaluated using 10% methylethene bis- 
acrylamide non- denaturing gel electrophoresis. 1:10,000 SYBR Gold 
(Invitrogen, USA) was used to stain the gel and the gel was viewed using UV- 




3.4.1   Hair  follicle sheath cells were isolated from human hair follicle 
samples 
As shown in Fig.3.1, the hair follicle sheath tissue was separated from hair 
follicle after incubating hair follicle in 0.1% collagenase-Dispase. The 
connective sheath tissue was carefully minced and treated in 0.25% trypsin. 
The sheath cells were isolated from the connective tissue; they readily 
attached onto tissue culture plastic dishes, and formed large colonies after 
plating for 10-12 days (Fig.3.2).  
 
Fig.3.1  Micro-dissection of human hair follicle. A: Single human hair follicle was 
isolated from scalp tissue under inverted miscroscopy. B: The hair follicle sheath has 
been carefully dissected by micro-dissection away from the main shaft of the hair 
follicle.  
 
Fig.3.2 In vitro culture of human hair sheath cells, single human hair sheath cell was picked 
out manually and seeded with medium of DMEM supplemented with 20% fetal bovine serum. 
The sheath cell formed sparse colonies after plating for 4-5 days (A); and big compact 
colonies with thousands of cells were observed after 10-12 days (B).   
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3.4.2    Hair follicle sheath cells show great proliferation capacity in vitro 
To investigate the growth potential of the sheath cells, they were plated onto 
petri-dish, and the accumulated population doubling (PD) was calculated 
according to the following formula: : PD = (log N/N0)/log2, where N 
represents the total number of cells obtained at each passage, N0 represents 
the number of cells plated at the beginning of the experiment.  As shown in 
Fig. 3.3, the sheath cells display a PD value 4-5 at each passage, and the 
sheath cells can be maintained for more than 10 passages.   
 
 
Fig.3.3  Population doubling assay of human hair follicle sheath cells. Hair follicle 
sheath cells were serially subcultured until their growth potential was exhausted 
(which happened after 10-11 passages, roughly 40-50 population doublings). 
Triplicate cultures in each clones were cultured, total 10 sheath cell strains from 5 
individuals were analyzed. The number of cumulative population doublings was 
calculated using the following formula: PD = (log N/N0)/log2, where N represents 
the total number of cells obtained at each passage and N0 represents the number of 
cells plated at the start of the experiment. The figure shown here is a representative 






































3.4.3   Hair follicle sheath cells display high colony forming efficiency 
To investigate their colony forming capacity, hair follicle sheath cells at 
passage 3, 6, 8 were trypsinized, and 200 cells were plated into one dish for 
CFE assay. As shown in figure 3.4, the CFE for sheath cells was 73.0+ 1.8% 
(A), while the CFE for bone marrow derived mesenchymal stem cells was 
61+2.1% (B), which was taken as a control for sheath cells.  
   
 
Fig.3.4 Colony forming efficiency (CFE) assay of hair follicle sheath cells. Human 
hair follicle sheath cells were trypsinized and plated onto petri dish at a density of 200 
cells/dish, and allowed to grow for 12 days. After that, the dishes were stained with 
crystal violet, and the colony numbers were counted and the CFE was calculated. A: 
CFE of hair follicle sheath cells; B: Human bone marrow derived MSCs were used as 
control.   
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3.4.4    Hair follicle sheath cells display a phenotype similar to that of BM-
MSCs 
The phenotype of hair follicle sheath cells was determined by examining the 
expression of CD surface markers. As shown in Fig3.4, the sheath cells were 
strongly stained with  CD105, CD29, CD49b and CD49d, while weakly 
stained with CD90, CD44, CD34 and CD45. The hair follicle sheath cells 
showed the phenotype of menenchymal stem cells, which was similar to that 
of bone marrow mesenchymal stem cells. The exception is that CD90 and 
CD44 were weakly expressed. As expected, CD34 and CD45, which are 
surface markers of hematopoietic lineages, were only weakly expressed in 
sheath cells.  
Fig. 3.5 The expression of CD markers in hair follicle sheath cells. The hair follicle 
sheath cells were stained with antibodies against CD105, CD29, CD49b, CD49d, 
CD90, CD44, CD34 and CD45. The hair follicle sheath cells (black peaks) were 
strongly stained with  CD105, CD29, CD49b and CD49d, while weakly stained with 
CD90, CD44, CD34 and CD45. Isotype controls were shown in red peaks.   
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3.4.5 Hair follicle sheath cells can be differentiated into osteoblasts, 
chondrocytes and adipocytes in vitro.  
To investigate their potential of differentiating into osteoblasts, chondrocytes 
and adipocytes, hair follicle sheath cells were induced in osteogenic, 
adipogenic and chondrogenic medium respectively. After inducing for 2 
weeks, the hair follicle sheath cells were subjected to histological staining and 
gene expression analysis of lineage marker genes. During osteogenic 
differentiation, hair follicle sheath cells formed a mineralized matrix as 
demonstrated by von kossa staining (Fig.3.6.A), and showed induction of 
osteogenic gene expresson: osteopontin, osteocalcin, osteonectin, CBFa-1 and 
alkaline phosphatase.
 
Fig.3.6.A In vitro osteogenic differentiation of human hair sheath cells. Human hair 
sheath cells were induced in osteogenic medium. Von Kossa staining showed 
formation of calcium nodule (black) after induction for 2 weeks, cell nucleus were 
counterstained with nuclear fast red. RT-PCR analysis showed induction of 
osteogenic genes, including ostopontin, osteocalcin, osteonectin, CBFa-1 and alkaline 
phosphatae, after 7-14 days of induction.  
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For adipogenic differentiation, Oil red O staining showed that lipid-filled 
vesicles were present in most hair follicle sheath cells; and adipogenic marker 
genes, which include aP2, lipaoprotein lipase, PPARr1, PPAR r2, leptin and 
GLUT4, were observed increase after induced for 7-14 days.  
 
 
Fig.3.6.B. In vitro adipogenic differentiation of human hair sheath cells. Human hair 
follicle sheath cells were induced in adipogenic medium. Oil O staining showed lipid-
filled vesicles (red) were present in most sheath cells. RT-PCR analysis showed that 
adipogenic genes, including aP2, lipaoprotein lipase, PPARr1, PPARr2, leptin and 























For chondrogenic differentiation, human sheath cell pellet was induced in 
chondrogenic medium. Alcian blue staining showed blue staining of cartilage 
extracellular matrix formation after induction for 3 weeks. RT-PCR analysis 
showed that the chondrogenic genes, including aggrecan, collagenII, 




Fig.3.6.C. In vitro chondrogenic differentiation of human hair sheath cells. Human 
hair follicle sheath cells were induced in chondrogenic medium. Alcian blue staining 
showed cartilage extracellular matrix formation (blue). RT-PCR analysis showed that 
chondrogenic genes, including aggrecan, collagenII, collagenX, were upregulated 













3.4.6.   Hair follicle sheath cells show high telomerase activity 
To study the telomerase activity of hair follicle sheath cells, this cell 
population  at passage 1, 3, 5, 8 and 10 was used, and HeLa cells were used as 
positive control. As shown in figure 3.7, passage 1 of sheath cells showed a 
high level of telomerase activity, which was similar to that of HeLa cells, the 
positive control; the telomerase activity of sheath cells was observed decrease 
in passages 3, 5, 8 and 10, compared to passage 1.  
 
   
Fig.3.7 Telomerase activity assay of hair follicle sheath cells. Hair follicle sheath 
cells at passage 1, 3, 5, 8 and 10 were used, and HeLa cells were used as positive 
control. The protein extracts of sheath cells at different passages were used for PCR, 
the PCR products were subjected to 10% methylethene bis-acrylamide non-
denaturing gel electrophoresis,  the SDS-PAGE gel was subsequently stained with 
0.01% SYBR Gold, and viewed using UV- radiation. A: HeLa cells (positive control) 
showed many bands, which marked the high telomerase activity, while passage 1 
sheath cells showed similar level of telomerase activity as in HeLa cells, the sheath 
cells showed a slight lower level of telomerase activity in passage3, 5, 8 and 10, 
compared to passage1. B: The protein extracts of sheath cells and HeLa cells were 
used for PCR, the amplification curves showed that passage 1 sheath cells and HeLa 
cells were amplified early, compared to passage 3, 5, 8, 10 of sheath cells, which was 
identical to the electrophoresis results in A. M: marker. 
    
  M     P1    P3    P5   P8    P10  Hela 
A                                             B 
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3.5.    DISCUSSION 
Mesenchymal stem cells are multipotent adult stem cells, having the capacity 
to differentiate into mesodermal lineages and other cell lines. MSCs are 
usually cultured and expanded prior to their application. MSCs have a limited 
lifespan in vitro as any other normal somatic cell (Digirolamo, Stokes et al. 
1999). After a certain number of cell divisions, MSCs enter senescence, which 
is morphologically characterized by enlarged and irregular cell shapes and 
ultimately stop proliferating, reflecting the aging process of MSCs; also MSCs 
showed attenuated expression of specific surface markers (Stenderup, Justesen 
et al. 2003). 
 
The molecular mechanisms that underlie cell senescence are still poorly 
understood. Two fundamental ways have been hypothesized for cell 
senescence: replicative senescence might either be the result of a purposeful 
programme driven by genes or rather be evoked by stochastic or random, 
accidental events (Wright and Shay 2002). Most likely, it is an interplay of 
both mechanisms that promotes aging at various levels. Progressive shortening 
of the telomeres or modified telomeric structure has been associated with 
replicative senescence although this mechanism is unlikely to be the only 
cause of this phenomenon. There is also evidence that senescence involves 
DNA damage, accumulation of the cyclin-dependent kinase inhibitor p16
INK4a
 
and oxidative stress. Clearly, cellular senescence is a complex process and the 
sequence of its molecular events is thus far unknown. Additionally, it is not 
known how senescence influences the overall gene expression in MSC. 
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Hair follicle sheath cells have a myofibroblast or wound healing phenotype. In 
animals with high follicle densities, differences in wound healing are observed 
in conjunction with changes in the hair growth cycle (Panteleyev, Jahoda et al. 
2001). Similarly, in human beings there are apparent differences in wound 
healing responses between hairy and non-hairy body sites. Moreover, clinical 
and experimental data suggest that the involvement of follicle-derived dermal 
cells results in qualitatively improved dermal repair (Waters, Richardson et al. 
2007). With this knowledge in mind, we hypothesize that the human HFS-
MSCs perform an important function in the repair of skin dermis after injury, 
with a mechanism which is still unknown.  
 
In this project, we successfully isolated and cultivated the clonal human hair 
follicle sheath (HFS) cells. These cells showed extensive proliferative ability 
and clonogenic capacity in in vitro culture; also they show a phenotype which 
is similar to that of bone marrow mesenchymal stem cells. The human HFS 
cells were successfully induced into mesenchymal lineage: osteoblasts, 
chondrocytes and adipocytes, they also showed high telomerase activity which 
was not observed in bone marrow derived MSCs. The identification and 
characterization of these hair follicle sheath derived mesenchymal stem cells 
will provide a novel alternative source to human bone marrow derived 
mesenchymals stem cells, and these cells have great potential in stem cell 







 ABCG2 identifies clonogenic keratinocytes in human 




4.1  SUMMARY 
ABCG2, a member of the ATP binding cassette (ABC) transporters, has been 
recognized as a universal marker for stem/progenitor cells in many tissues and 
organs. This study investigated the expression of ABCG2 in the human 
interfollicular epidermis, and its potential as a surface marker for identifying 
clonogenic epidermal keratinocytes. Immunofluorescent and western blot 
studies showed that the ABCG2 was exclusively localized in the basal layer of 
human interfollicular epidermis, not in the suprabasal layer. Flow cytometry 
analysis showed approximately 2.1-3.3% of keratinocytes in interfollicular 
epidermis express ABCG2, and this cell population  expresses p63, β1-
integrin, α6-integrin, cytokeratin14, but not CD34, CD71, C-kit and 
involucrin. The ABCG2-positive keratinocytes showed significant higher 
colony forming efficiency (CFE) on 3T3 feeder layer than ABCG2-negative 
keratinocytes, and extensive proliferation capacity in long-term in-vitro 
culture. With clonal analysis, most of the freshly isolated ABCG2-positive 
keratinocytes formed holoclones and were capable to form stratified epidermis 
in organotypic model. These data indicate that ABCG2 is exclusively 
expressed by basal keratinocytes in human interfollicular epidermis and this 
population of cells possesses keratinocyte stem cell properties, suggesting that 
ABCG2 might be useful for enriching keratinocyte stem cells derived from 







4.2  INTRODUCTION 
It has been shown that human keratinocyte stem cells (KSCs) are localized in 
the basal layer of the epidermis, in the interfollicular epidermis and the hair 
follicle. Most attention has been concentrated on analysis of the different 
populations of stem cells in the hair follicle, especially in the bulge region of 
the hair follicle (Cotsarelis, Sun et al. 1990; Jones and Watt 1993; Rochat, 
Kobayashi et al. 1994; Jones, Harper et al. 1995). These cells are found to be 
slow-cycling or rarely cycling cells during homeostasis in-vivo, with a high 
capacity for error-free self-renewal, and superior clonogenicity and 
proliferation capacity (Bickenbach and Chism 1998; Morris and Potten 1999; 
Blanpain, Lowry et al. 2004; Tumbar, Guasch et al. 2004). The KSCs have 
been detected by labeling the skin with titrated thymidine, 
bromodeoxyurindine (BrdU) or by clonal analysis (Barrandon and Green 
1985; Kobayashi, Rochat et al. 1993; Rochat, Kobayashi et al. 1994; Morris 
and Potten 1999). It is difficult to use these methods for isolating living cells 
for stem cells biology studies and clinical use, because the cells have to be 
fixed or permeabilized in the above analysis. Several potential molecular 
markers for identifying KSCs have been investigated: β1-integrin, cytokeratin 
19, CD34, p63, α6briCD71dim, Rac1, MTS24, survivin (Jones and Watt 1993; 
Michel, Torok et al. 1996; Tani, Morris et al. 2000; Pellegrini, Dellambra et al. 
2001; Trempus, Morris et al. 2003; Benitah, Frye et al. 2005; Nijhof, Braun et 
al. 2006; Marconi, Dallaglio et al. 2007). However the identity of human 
interfollicular KSCs remains unknown (Kaur 2006). There is great need to 
characterize these cells and apply them in cell transplantation and gene 
therapy (Kaur 2006).  
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ABCG2, previously known as breast cancer resistance protein 1 (BCRP1), is a 
member of the multidrug resistance protein (MRP) family (Zhou, Schuetz et 
al. 2001). MRPs are associated with resistance to some carcinostatics and are 
over-expressed in several cancer cell lines. Recently, it was discovered that 
ABCG2 expression is associated with the side population (SP) cell phenotype 
based on their ability to exclude Hoechst 33342 dye in many tissues (Goodell, 
Brose et al. 1996; Zhou, Schuetz et al. 2001; Zhou, Morris et al. 2002). 
ABCG2 has been investigated and characterized from various tissues and 
organs, including hematopoietic system, skeletal muscle, mammary gland, 
breast and limbus (Scharenberg, Harkey et al. 2002; Montanaro, Liadaki et al. 
2003; Clayton, Titley et al. 2004; Pearce, Ridler et al. 2004; Budak, Alpdogan 
et al. 2005; Clarke, Spence et al. 2005; de Paiva, Chen et al. 2005), and it was 
suggested that expression of ABCG2 gene is a conserved feature of stem cells 
from a wide variety of tissues.  
 
A few studies investigated the SP keratinocytes using Hoechst excluding assay 
(Terunuma, Jackson et al. 2003; Triel, Vestergaard et al. 2004; Yano, Ito et al. 
2005; Larderet, Fortunel et al. 2006; Redvers, Li et al. 2006; Terunuma, 
Kapoor et al. 2007). SP cells in many tissues were shown to express ABCG2 
transporter (Zhou, Schuetz et al. 2001); however this point has not been 
demonstrated in human skin keratinocytes (Triel, Vestergaard et al. 2004; 
Larderet, Fortunel et al. 2006). At the start of the present study, it was not 
known which if any cell types in human interfollicular epidermis express 
ABCG2 protein, and whether these cells possess the characteristics of stem 
cells. A series of experiments was therefore designed to investigate the 
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expression of ABCG2 in human interfollicular epidermis, and to investigate 
ABCG2-positive cell properties with functional assays. This chapter indicates 
that ABCG2 is indeed specifically expressed in the basal layer of epidermal 
keratinocytes of interfollicular epidermis, and ABCG2-positive keratinocytes 
showed most of the keratinocyte stem cells properties similar to that of 
α6briCD71dim cells, suggesting that ABCG2 might be a useful biomarker for 
interfollicular keratinocyte stem cells, and moreover, one which can be used to 
enrich for interfollicular keratinocyte stem cells due to its surface expression 
for clinical usage.   
 
4.3  MATERIALS AND METHODS 
4.3.1  Isolation and cultivation of keratinocytes from human skin 
Normal fresh human skin samples were obtained from plastic surgery 
operations of healthy subjects, and the procedure was approved by the ethics 
committee of Singapore General Hospital. Human skin samples from 10 
donors were used in this study. Human skin samples were washed in 
phosphate-buffered saline (PBS) and incubated in 0.25% Dispase II (Roche, 
Singapore) overnight at 4 
0
C; epidermis was separated form dermis with fine 
forceps. Epidermis was then minced and incubated in 0.05% trypsin-EDTA 
(Gibco, Invitrogen, Singapore) at 37 
0
C for 15 minutes. Keratinocytes from 
epidermis were collected and suspended in PBS and filtered on a 40-micron 
filter (Falcon, Becton Dickinson, Singapore) to get a single cell suspension 








 on a 
lethally -irradiated 3T3-J2 feeder layers as previously described (Rheinwald 
and Green 1975). The keratinocytes were cultured at 37 
0
C in 10% CO2 and 
humidified atmosphere. The culture medium was a mixture of Dulbecco's 
Modified Eagle's Medium (DMEM, Gibco, Invitrogen, Singapore) and Ham’s 
F12 (Gibco, Invitrogen, Singapore) at a ratio of 3:1, containing 10% fetal 
bovine serum (Hyclone, Logan, UT, USA), insulin (5 g/ml), adenine (0.18 
mM), hydrocortisone (0.4 g/ml), cholera toxin (0.1 nM), triiodotyronine (2 
nM), epidermal growth factor (10 ng/ml), L-glutamine (4 mM), penicillin-
streptomycin (50 IU/ml). All the reagents were from Sigma of Singapore 
unless specified otherwise. The culture medium was changed every 3 days, 





Keratinocytes were serially cultivated as above.  
 
4.3.2  Immunofluorescent staining of skin 
Fresh human skin samples were embedded in OCT embedding media (Sakura, 
Torrance, CA, USA). Skin frozen sections (5 μm) were cut with a cryostat 
(Leica, Houston, TX, USA) and stored at -80°C until use. Immunofluorescent 
staining was performed as previously described (Yano, Ito et al. 2005). In 
brief, human skin sections were fixed with 4% paraformaldehyde at 4°C for 15 
minutes, after blocking with 5% goat serum in PBS for 30 minutes, anti-
ABCG2 antibody (clone BXP-21, Millipore, Singapore) was used at a 1:25 
dilution in PBS at room temperature for 1 hour. After washing with PBS three 
times, Alexafluor-488 conjugated secondary antibody (1:200, Gibco, 
Invitrogen, Singapore) was applied for 1 hour in a dark chamber. After repeat 
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washing with PBS three more times, the slides were mounted with Vectashield 
fluorescent mounting medium containing 4'-6-diamidino-2-phenylindole 
(DAPI, Burlingame, CA, USA) and covered with cover slips. The slides were 
visualized and photographed with a fluorescent microscope (Axiovert 200, 
Carl Zeiss, Singapore).  
 
4.3.3  Western blot analysis 
Each population of sorted ABCG2-positive, ABCG2-negative keratinocytes 
and unsorted keratinocytes from human epidermis were collected, centrifuged 
at 4 
0
C, and the cell pellets were homogenized in RIPA buffer (1% Nonidet P-
40, 0.5% sodium deoxycholate, 150 mM sodium chloride, 1mM 
phenylmethylsulfonyl fluoride and 1 g/ml leupeptin) at 4 0C. The cell protein 
lysates was quantified using a BCA kit (Pierce, Rockford, IL, USA). Equal 
amount of protein was electrophoresed in a 7.5% SDS-polyacrylamide gel, 
transferred onto a nitrocellulose membrane. The membrane was blocked with 
2% bovine serum albumin in Tris-buffered saline (TBS) for 3 hours, washed 
with TBS for 1 hour, and incubated with anti-ABCG2 antibody (BXP-21, 
1:100, Millipore, Singapore) diluted in TBS with 0.1% Tween-20 overnight at 
4 
0
C.  After washing, anti-mouse IgG (HRP-conjugated, 1:2000, Santa Cruz, 
CA, USA) was applied for 1 hour at room temperature. Finally 
chemiluminescence visualization was carried out using the Supersignal 






4.3.4  Flow cytometry analysis and cell sorting   
Freshly isolated human epidermis keratinocytes were dissociated using typsin 
(0.05%) and were suspended at a concentration of 10
6
 cells/ml in staining 
medium (DMEM containing 2% FBS and 10 mM HEPES), incubated with 
anti-ABCG2 antibody (clone 5D3, 1:25, BD Biosciences, Singapore) for 30 
minutes on ice, washed with PBS containing 1% FBS, then incubated with 
Alexafluor-488 conjugated rabbit anti-mouse secondary antibody (1:200, 
Gibco, Invitrogen, Singapore) for 30 minutes, washed with PBS/1% FBS 5 
minutes three times, and re-suspended in staining medium. The cells were kept 
on ice until flow cytometry analysis was performed. Fluorescence-activated 
cell sorting (FACS) was performed at National University Medial Institute 
(NUMI, Singapore) with a FACSadvantage SE (BD Biosciences, Mountain 
View, CA) cell sorter.  
 
To characterize the phenotype ABCG2-positive and ABCG2-negative 
keratinocytes, the sorted cells were stained for 30 minutes at 4 
0
C with 
following anti-human antibodies against α6-integrin, β1-integrin, CD34, 
CD71, keratin 14 (Phycoerythrin [PE]-conjugated, 1:100, all from BD 
Biosciences, Mountain View, CA, USA), p63 (1:200, Santa Cruz, CA, USA). 
 
4.3.5  Clonal analysis  
After sorting with anti-ABCG2 antibody, single keratinocytes were picked 
under inverted microscope as previously described (Barrandon and Green 
1987) and seeded in a 35 mm petri-dish containing lethally irradiated 3T3 
feeder layer. After 7 days of culture, the colonies were identified under phase 
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contrast microscope. Each colony was then transferred to two 100 mm petri-
dishes, one indicating dish (1/4 of the colony) was fixed after culturing for 12 
days and stained with 1% Rhodamine B for the classification of colony types, 
the other dish (3/4 of the colony) was used for serial propagation and further 
analysis. The colony type was determined by the percentage of aborted 
colonies formed by the progeny of the seeding keratinocytes (Barrandon and 
Green 1987). Selected colonies were serially cultivated and passaged as above 
until they stop proliferating.  
 
4.3.6  Colony forming efficiency (CFE) assay  
To evaluate CFE, the populations of ABCG2-positive, ABCG2-negative and 
unsorted keratinocytes were collected, 100 cells of each population were 
seeded onto 100 mm petri-dish containing irradiated 3T3 feeder layer, and 
they were allowed to grow for 12 days. The culture medium was changed 
every 4 days.  At the end of culture period, the culture was fixed with formalin 
and stained with 1% Rhodamine B. The CFE was then calculated and 
expressed as a percentage of the number of plating cells.  
 
4.3.7  Long term keratinocytes expansion assay  
ABCG2-positive, ABCG2-negative and unsorted keratinocytes were cultured 
on lethally irradiated 3T3 feeder layer. After keratinocytes reached 70-80% 
confluence, cells were trypsinized, and seeded at a density of 5000 cells/cm
2
. 
Cultures were serially passaged until the proliferation capacity of the 
keratinocytes was exhausted. The number of population doublings (PD) was 
calculated according to the following formula: PD = (log N/N0)/log2, where N 
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represents the total number of cells obtained at each passage, N0 represents the 
number of cells plated at the beginning of the experiment.  
  
4.3.8  RNA isolation and reverse transcription PCR (RT-PCR) analysis 
Total RNA from ABCG2-positive, ABCG2-negative and unsorted 
keratinocytes were isolated using the RNeasy kit (Gibco, Invitrogen, 
Singapore). The RNA was quantified by its absorbance at 260 nm using 
NanoDrop (ND-1000, Wilmington, DE, USA) and stored at -80°C until use. A 
housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
was used as an internal control for protein loading. The mRNA expression 
level of different molecular markers was analyzed by semi-quantitative RT-
PCR as previously described [19]. Briefly, 1 μg of total RNA was used to 
synthesize first strand cDNAs with Superscript first-strand System (Gibco, 
Invitrogen, Singapore). PCR amplification was performed with specific primer 
pairs designed from published human gene sequences for different markers 
[19]. The fidelity of the RT-PCR products was verified by comparing their 
size with expected cDNA bands and sequencing the PCR products. The PCR 
products were also visualized on 1.8% agarose gel.  
 
4.3.9  Reconstructing epidermis with organotypic culture  
Glycerol-preserved allogenic skin (GPA, EURO SKIN BANK, EA Beverwijk, 
Netherland) was used and washed in PBS containing penicillin-streptomycin 
(50 IU/ml). The epidermis was removed mechanically after 3 cycles of snap-
frozen and thawing. The de-epidermalized dermis (DED) was cut into 2 x 2 
cm squares, and a 1 cm diameter stainless steel ring was placed on the 
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reticular side of each dermis square. Normal primary human dermal 
fibroblasts were seeded at 5 x 10
5
 cells per ring and grown for 1 day. Then the 
ABCG2-positive and ABCG2-negative keratinocytes were plated at 2 x 10
5
 
cells per ring respectively, grown in keratinocyte cFAD culture medium for 
four days to reach a confluent monolayer. Then the cultures were lifted and 
cultured at the air-liquid interface for 10 days. The cultures were embedded, 
snap frozen in liquid nitrogen; frozen sections were cut at 5 μm and stained 
with haematoxylin and eosin.  
 
4.3.10 Statistical Analysis 
The CFE data was presented as mean ± SEM, as indicated in the Figure 4.3, 
Figure 4.6, Tab 4.1 and Tab 4.2. Differences between mean values were 
analyzed with Student’s t-test, and p < .05 was considered statistically 
significant. 
 
4.4  RESULTS 
4.4.1  ABCG2 expression is restricted to basal layer of human skin 
epidermis 
In human skin, the ABCG2 protein was found in small basal layer 
keratinocytes in interfollicular skin epidermis (Fig. 4.1.), and both cell 
membrane and cytoplasm staining were observed. No ABCG2 expression was 
detected in the suprabasal keratinocytes. In contrast, there was minimal 
ABCG2 staining in the skin dermis. This staining pattern is similar to that of 
the transcription factor p63: positive staining was seen in isolated small 
clusters of basal keratinocytes, interspersed with large area of negative 
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staining cells [16, 49]. This staining pattern is similar to previous reports of 
ABCG2 staining in mouse skin and human corneal limbus (de Paiva, Chen et 
al. 2005; Yano, Ito et al. 2005).  Western blot analysis revealed a single protein 
band with a molecular weight of approximately 72 KDa was detected in whole 
skin, epidermis, ABCG2-positive keratinocytes and A549 cells (Fig.4.2.A). As 
expected, high expression of ABCG2 was detected in ABCG2-positive 
keratinocytes, followed by epidermis and whole skin, while dermis expressed 
little if any ABCG2. These results indicate that ABCG2 is exclusively 
expressed in the basal layer of human skin interfollicular epidermis.  
 
Fig.4.1 Localization of ABCG2 in human interfollicular skin. Immunofluorescent 
staining of human interfollicular skin with anti-ABCG2 antibody (Clone: BXP-21). 
Green bright staining of ABCG2 was seen in cluster small cells of basal layer 
keratinocytes (white arrow) on their cells membrane; whereas suprabasal 
keratinocytes were not stained. Cell nuclei are counterstained with DAPI (blue). 




4.4.2 ABCG2 expression proportion in human skin epidermis 
To figure out the proportion of ABCG2 expression in skin epidermis, flow 
cytometry analysis was performed using the anti-ABCG2 antibody (Clone 
5D3). Keratinocytes positively stained with ABCG2 antibody accounted for 
2.7 ± 0.6% (Fig.4.3.A, region M1, mean ± SD, n = 5) of freshly isolated 
keratinocyte population, and 2.8 ± 0.3% (Fig. 4.3.B, region M1, mean ± SD, n 
= 5) of primary epidermal keratinocyte cultures. ABCG2 expression in the 
cells sorted by FACS was confirmed by comparing the levels of ABCG2 
mRNA detected by RT-PCR in ABCG2-positive and ABCG2-negative 
populations. ABCG2 was highly expressed in the ABCG2-positive  population 
and A549 cell line, which was taken as a positive control, whereas it was 
barely detectable in ABCG2-negative population. There was no difference in 
GAPDH expression among these three groups (Fig.4.2.B). 
 
Fig.4.2 Localization of ABCG2 in human skin by western blot and RT-PCR assay. 
2A: Western blot analysis of ABCG2 expression in human skin. It is shown that 
epidermis and positive control (A549 cell line) expressed ABCG2, dermis tissue did 
not, and full-thickness skin expresses a low level of ABCG2. 2B: RT-PCR analysis of 
ABCG2 mRNA expression in sorted keratinocytes. Higher expression of ABCG2 
mRNA (379bp) was shown in ABCG2-positive keratinocytes sorted by FACS, while 
lower expression of ABCG2 mRNA was detected in ABCG2-negative keratinoctyes. 
A549, a human alveolar cancer cell line, was used as positive control. A 100 bp DNA 






Fig.4.3 Flow cytometry analysis of ABCG2 expression in human skin keratinocytes. 
A: Fresh isolated epidermal keratinocytes were incubated with anti-ABCG2 antibody 
(Clone: 5D3), and Alexafluor-488 conjugated secondary antibody was used. ABCG2-
positive cells (green line, region M1) accounted for 2.7% + 0.12%, isotype control 
was shown in blue line, and blank control was shown in red line. B: Primary cultured 
epidermal keratinocytes were harvested and incubated with anti-ABCG2 antibody; 
2.8% + 0.18% cells showed ABCG2-positive staining (green line, region M1). The 
flow analyses were repeated 5 times, and the results were averaged.  
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4.4.3  ABCG2 positive keratinocytes show typical phenotype of 
epidermal stem cells 
The phenotype of ABCG2-positive and ABCG2-negative keratinocytes was 
determined by examining the expression of several known molecular markers. 
As shown in Figure 4.4, ABCG2-positive keratinocytes were strongly stained 
with  α6-integrin, β1-integrin, keratin 14 and p63, compared to ABCG2-
negative keratinocytes; whereas ABCG2-positive keratinocytes were weakly 
stained by CD34, CD71, C-Kit and involucrin compared with ABCG2-
negative keratinocytes. These data indicate that ABCG2-positive keratinocytes 
express high levels of several potential stem cell markers, while expressing 
low levels of differentiation markers.  
 
Fig.4.4 Expression of stem cells markers in human epidermis keratinocytes. ABCG2-
positive and ABCG2-negative keratinocytes were sorted out separately as in Fig.4.3. 
ABCG2-positive cells (blue line) were more strongly stained with α6-integrin, β1-
integrin, keratin 14, p63 than ABCG2-negative cells (green line); CD71 and 
involucrin were weakly stained in ABCG2-positive cells; both ABCG2-positive and 
ABCG2-negative cells were negative stained for CD34 and C-kit. Isotype controls are 
shown as a red line.  
a6-integrin                 β1-integrin                keratin 14                    p63                 






4.4.4  ABCG2 positive keratinocytes show high CFE 
Next we examined the CFE and the colony types for each population of 
keratinocytes. To analyze the CFE, ABCG2-positive and ABCG2-negative 
keratinocytes were seeded at a density of 100 cells per 100mm petri-dish, 
which was pre-seeded with lethally irradiated 3T3 feeder layer, and allowed to 
grow for 12 days. We found that the differences in colony appearance between 
two sorted keratinocyte populations were very obvious. Fig.4.5 shows 
examples of the different colonies observed in ABCG2-positive and ABCG2-
negative keratinocyte cultures. Large colonies were observed in ABCG2-
positive cultures (Fig.4.5.A) but not in the ABCG2-negative cultures 
(Fig.4.5.B). Also, most of the colonies formed by ABCG2-positive population 
were composed of small actively growing keratinocytes; while most of the 
cells in ABCG2-negative colonies were very big and mostly abortive within 4 
weeks.  
 
Fig.4.5 Colonies formed by ABCG2-positive keratinocytes and ABCG2-negative 
keratinocytes. ABCG2-positive and ABCG2-negative keratinocytes were sorted and 
seeded onto lethally irradiated 3T3 feeder layer, allowed to grow for 7 days. A: 
ABCG2-positive keratinocyte formed large colony, composed of small and actively 
growing keratinocytes; B: ABCG2-negative keratinocyte formed small colonies, with 





As shown in Figure 4.6, the CFE value for ABCG2-positive, ABCG2-negative 
and unsorted keratinocytes were 85% ± 2.1%, 27% ± 1.8% and 31% ± 2.3% 
respectively. The ABCG2-positive keratinocytes exhibited statistically 
significant higher CFE and larger colony size compared to ABCG2-negative 
keratinocytes and unsorted cells (Fig. 4.6, p < .01, n = 5). No difference in 
CFE were found between ABCG2-negative cells and unsorted cells (Fig. 4.6, 
p > .05, n = 5).   
 
 
Fig.4.6 Colony forming efficiency (CFE) of ABCG2-positive, negative and unsorted 
keratinocytes. A: ABCG2-positive and negative keratinocytes were sorted out as in 
Fig.3, 100 cells of each population were seeded in 100 mm petri-dish pre-seeded with 
lethally irradiated 3T3 feeder layer, and CFE was evaluated at day 12. B: The 
ABCG2-positive cells showed a greater number of colonies than the ABCG2-
negative cells (CFE, 85% ± 2.1% versus 27% ± 1.8%, p < .01, n = 5), whereas there 
was no difference between ABCG2-negative cells and unsorted cells (CFE, 27% ± 




4.4.5  Majority of ABCG2 positive keratinocytes formed holoclones 
To investigate whether holoclones, meroclones and paraclones, as 
distinguished by Barrandon and Green, were present in ABCG2-positive 
keratinocytes and ABCG2-negative keratinocytes, single cells were isolated 
from these two cell populations obtained from 5 different donors, and seeded 
onto 35mm petri-dish pre-seeded with lethally irradiated 3T3 feeder layer. 
After 7 days of culture, each colony was transferred to 2 dishes, one dish for 
serial propagation and further analysis, and the other one was for colony 
identification. In total, 300 clones from 5 donors were analyzed. We found that 
73.67% ± 1.21% of clones from ABCG2-positive keratinocytes were 
holoclones. Meroclones and paraclones were present in less than 27%. For 
ABCG2-negative cells, the holoclones were less than 4%; 95% of the clones 
were meroclones and paraclones (Tab.4.1, Figure. 4.7). The holoclones, 
meroclones and paraclones obtained from the same donors were then serially 
cultivated to evaluate their proliferative capacity. The holoclones were found 
to produce 120-140 cell generations before they stopped proliferating, while 
meroclones were able to undergo 20-42 cell divisions, and paraclones only 
underwent 5-10 cell divisions before exhausting their proliferation capacity 
(Tab.4.2, Figure.4.8). 






Tab.4.1 The clonogenic potential of human interfollicular epidermis primary sorted 
ABCG2-positive (ABCG2+) keratinocytes and ABCG2-negative keratinocytes. H: 
holoclone; M: meroclone; P: paraclone. Keratinocyte from five donors were isolated, 
and ABCG2+ and ABCG2-negative keratinocytes were sorted out respectively, and 







Tab.4.2 The cumulative population doubling (PD) of ABCG2+ keratinocytes in long 
term culture. To investigate their proliferative capacity in long term culture, ABCG2-
positive keratinocyte clones from five donors were serially cultured until they stop to 
proliferate (last 5 months), and the cumulative PDs was calculated accordingly.  














Fig.4.7 Clonal analysis of ABCG2-positive epidermis keratinocytes. ABCG2-positive 
cells were FACS-sorted. In total, 300 single cells from 5 donors were picked and 
inoculated into 35mm petri-dish pre-seeded with lethally irradiated 3T3 cells. Seven 
days later, 1/4 of each resulting colony was trypsinized, and transferred to an 
indicator dish. These dishes were fixed, stained and analyzed 12 days later as 
previously described [34]. The holoclones, meroclones and paraclones shown here are 










Fig.4.8 The proliferation potential of primary keratinocytes in long term culture. 
ABCG2-positive keratinocytes were FACS-sorted; holoclones (H), meroclones (M) 
and paraclones (P) were identified, and serially subcultured on lethally irradiated 3T3 
feeder layer until their growth potential was exhausted. Triplicate cultures in each 
keratinocyte clones were cultured, total 5 keratinocyte strains from 5 individuals were 
analyzed. The number of cumulative population doublings was calculated using the 
following formula: PD = (log N/N0)/log2, where N represents the total number of 
cells obtained at each passage and N0 represents the number of cells plated at the start 




4.4.6  ABCG2 positive keratinocytes form fully differentiated epidermis 
in organotypic culture 
We also compared the organogenic potential of each cell population. The 
sorted ABCG2-positive and ABCG2-negative keratinocytes were plated onto 
de-epidermized dermis (DED) substrate. As shown in Fig. 4.9, the ABCG2-
positive cells were able to form a pluristratified epidermis, being typical of a 
normal epidermal structure and cellular differentiation: i.e., a basal layer with 
polygonal keratinocytes oriented perpendicularly to the underlying DED, three 
to four layers of spinous cells, three to four layers of granular cells 
characterized by the presence of keratohyalin granules, and finally layers of 
anucleate, flattened cornified cells forming a compact stratum corneum (Fig. 
4.9.A). In contrast, ABCG2-negative cells only formed an irregular and 
disorganized epidermis with two to three layers of keratinocytes (Fig. 4.9.B). 
Increased thickness of epidermis in skin organotypic culture was attributed to 
the relatively greater number of clonogenic cells in both the basal and 
suprabasal layers. This result indicated that the clonogenic capacity was 
retained in ABCG2-positive keratinocytes but was lost in ABCG2-negative 
keratinocytes, thus these two cell populations could be clearly distinguished 








Fig.4.9 Epidermal reconstruction assay of ABCG2-positive and ABCG2-negative 
keratinocytes. Human skin epidermis ABCG2-positive and ABCG2-negative 
keratinocytes were FACS-sorted as in Fig.3 and plated on DED substrate. A: 
ABCG2-positive cells were seeded on top of DED, 1 week after seeding, stratified 
epidermis was formed, with a typical stratum granulosum and stratum corneum; B: 
ABCG2-negative cells were seeded on top of DED, 1 week later, differentiation was 
still poor and no typical stratified epidermis was formed (Scale bars: 100 µm).   
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4.5  DISCUSSION 
 
This work is the first report on the isolation and characterization of ABCG2 in 
human interfollicular epidermis. Here we show that the ABCG2 transporter 
was mainly localized in the basal layer of human interfollicular epidermis, not 
in the suprabasal layer. The ABCG2-positive keratinocytes made up  2.1-3.3% 
of the total epidermal keratinocytes. These cells exhibited a molecular profile 
that was p63-positive, β1-integrin-positive, α6-integrin-positive, keratin14-
positive, CD34-negative, CD71-negative, C-kit-negative and involucrin-
negative. The ABCG2-positive keratinocytes showed significantly higher 
colony forming efficiency (CFE) than ABCG2-negative keratinocytes. The 
ABCG2-positive keratinocytes also showed extensive proliferation capacity in 
long-term in-vitro culture, and most of the freshly isolated ABCG2-positive 
keratinocytes (74%) formed holoclones. Moreover, they formed pluristratified 
epidermis in an organotypic culture model. These data indicate that ABCG2 is 
exclusively expressed by basal keratinocytes in human interfollicular 
epidermis and this population of cells possesses keratinocyte stem cell 
properties, suggesting that ABCG2 might be a useful marker for enriching 
keratinocyte stem cells in human interfollicular epidermis. 
 
Previous studies showed that ABCG2 expression was present in both 
cytoplasm and cell membrane, and was confined to stem cells (Zhou, Schuetz 
et al. 2001; Zhou, Morris et al. 2002; Schinkel and Jonker 2003; de Paiva, 
Chen et al. 2005; Fetsch, Abati et al. 2006). Our immunofluorescent staining 
and western blot analysis showed that ABCG2 expression was specifically 
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localized to certain basal keratinocytes in human interfollicular epidermis, 
sparsely interspersed in basal layer keratinocytes, which is consistent with 
previous reports (Yano, Ito et al. 2005; Fetsch, Abati et al. 2006). We found 
that the proportion of ABCG2 expression in interfollicular epidermis 
keratinocytes was relatively higher than that from other tissues, such as bone 
marrow, 
 
For the molecular markers, it was noted that p63, β1-integrin, α6-integrin, and 
keratin14 were highly expressed in ABCG2 positive cells, while CD34, CD71, 
C-kit and involucrin were weakly expressed, as defined by the antibody 
markers used here. These results indicated that ABCG2-positive keratinocytes 
have the phenotype of basal layer keratinocytes and are not differentiated 
keratinocytes. C-kit is reported to be highly expressed in bone marrow stem 
cells, but weakly expressed in mouse skin keratinocyte stem cells (Goodell, 
Brose et al. 1996; Yano, Ito et al. 2005). CD34 was shown to be a marker for 
bulge stem cells in mouse (Trempus, Morris et al. 2003), and recent report 
indicated that it was weakly expressed in human hair follicle stem cells 
(Claudinot, Nicolas et al. 2005). Our study showed that ABCG2 expression 
was localized mainly to the basal layer of human epidermis, which is 
consistent with previous observations (Yano, Ito et al. 2005; Fetsch, Abati et 
al. 2006).  
 
Clonal analysis was first used to evaluate clones form in-vitro, according to 
the percentage of aborted colonies formed by the progeny of the seeding cell 
(Barrandon and Green 1987), clones were divided into holoclone, meroclone 
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and paraclone. Holoclone showed extensive proliferative potential in-vitro 
culture, with a mean cell generations of 120-160 in human skin keratinocytes. 
Recently, a transplantation assay of holoclones in the rodent model (Claudinot, 
Nicolas et al. 2005) indicated that holoclones maintained their stemness and 
multipotency in in-vitro culture. Therefore, holoclones can be considered as 
keratinocyte stem cells (Kobayashi, Rochat et al. 1993; Rochat, Kobayashi et 
al. 1994; Pellegrini, Dellambra et al. 2001; Claudinot, Nicolas et al. 2005). 
Our data showed that, in ABCG2+ keratinocyte population, approximately 
74% of cells were holoclones, while there was less than 5% of holoclones in 
ABCG2-negative cells. We feel confident that ABCG2+ keratinocytes exhibit 
a major subset of keratinocyte stem cells in human skin. Our results also 
showed that the ABCG2+ cells had cell divisions of 120-140, which is only a 
little lower, compared to previous proliferative potential report of holoclones 
(Barrandon and Green 1987). In the sorting of ABCG2+ keratinocytes, the UV 
laser power of the flow cytometer is approximately 100mW, which could have 
induced some DNA damage and reduced slightly the population doublings of 
ABCG2-positive keratinocytes.  
 
Most studies of ABCG2 have been focused on its potential role in generating 
the multidrug resistance phenotype in cancer cells and its expression in adult 
stem cells. It has been shown that ABCG2 expression was present in the 
cytoplasm membrane, and was limited to primitive stem cells (Zhou, Schuetz 
et al. 2001). ABCG2 was identified as a molecular determinant for bone 
marrow stem cells (Zhou, Morris et al. 2002), and it has been proposed as a 
universal marker for stem cells from a variety of tissues (Scharenberg, Harkey 
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et al. 2002; Montanaro, Liadaki et al. 2003; Clayton, Titley et al. 2004; Pearce, 
Ridler et al. 2004; Budak, Alpdogan et al. 2005; Clarke, Spence et al. 2005; de 
Paiva, Chen et al. 2005). Recently, it was reported that ABCG2 could serve as 
a marker to identify corneal limbal epithelial stem cells (Budak, Alpdogan et 
al. 2005; de Paiva, Chen et al. 2005). In human skin epidermis, the expression 
and functional roles of ABCG2 is unclear until the present. This chapter now 
describes a phenotypic and functional analysis of human ABCG2-positive 
keratinocytes. This study confirms the expression of ABCG2 in the basal layer 
of human interfollicular epidermis and its role in the identification of 
epidermal stem cells.  
 
In previous studies, the ABCG2 transporter has been suggested to be the 
molecular determinant for the SP cell phenotype in many tissues (Zhou, 
Schuetz et al. 2001; Scharenberg, Harkey et al. 2002; Zhou, Morris et al. 
2002). But recent studies have suggested that ABCG2 expression might not be 
a characteristic of SP keratinocytes (Toma, Akhavan et al. 2001; Terunuma, 
Jackson et al. 2003; de Paiva, Chen et al. 2005; Larderet, Fortunel et al. 2006), 
which would set them apart from stem cells in other tissues and organs. A 
recent study suggests that Hoechst 33342 could affect cell differentiation 
(Adamski, Mayol et al. 2007)], which might complicate the interpretation of 
SP keratinocyte study data. The complex and sensitive procedure of the 
Hoechst 33342 exclusion assay may contribute to this hot debate (Montanaro, 
Liadaki et al. 2004). To clarify this issue, expression of ABCG2 was studied in 
human interfollicular skin. FACS cell sorting was used to sort ABCG2-
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positive keratinocytes, and this cell fraction provided more stable and 
consistent data than the Hoechst exclusion assay.   
 
Identification and enrichment of keratinocyte stem cells is of major 
importance, as it allows scientists to investigate their biochemical properties, 
lineage and biochemical properties. KSCs have been identified by in-vivo 
label retention assays or by in-vitro by clonogenic assays (Cotsarelis, Sun et al. 
1990; Kobayashi, Rochat et al. 1993; Rochat, Kobayashi et al. 1994)], but 
neither of these methods can be used for in vivo isolation and purification of 
live keratinocyte stem cells because of their damaging effects. However many 
molecular markers or methods have been proposed to identify KSCs, 
including the transcription factor p63, keratin 19, α6-integirn, β1-integrin, 
CD71, desmoplakin protein, Rac1, MTS24, survivin, and a combination of 
cell kinetics and surface markers (Jones and Watt 1993; Michel, Torok et al. 
1996; Tani, Morris et al. 2000; Pellegrini, Dellambra et al. 2001; Trempus, 
Morris et al. 2003; Wan, Stone et al. 2003; Benitah, Frye et al. 2005; Nijhof, 
Braun et al. 2006; Croagh, Phillips et al. 2007; Marconi, Dallaglio et al. 2007).  
However, as no single marker has been universally adopted for identifying and 
isolating KSCs, the search for molecular markers for KSCs is worth exploring 
further (Wan, Stone et al. 2003; Kaur 2006).  
 
We have reported here a phenotypic and functional analysis of human 
epidermal ABCG2 positive keratinocytes. It was found that the number of 
cells expressing ABCG2 in interfollicular epidermal keratinocytes was 
relatively high, compared with that of other tissues, such as bone marrow, 
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which was reported to be 0.05% - 0.1%. In vivo studies suggest that KSCs 
constitute between 4-10% of the basal layer keratinocytes, depending on the 
methodology used (Tani, Morris et al. 2000). Our data of 2.1-3.3% is 
consistent with these previous observations.  
 
In conclusion, this chapter demonstrates that ABCG2+ keratinocytes can be 
isolated from human skin interfollicular epidermis, yielding a positive fraction 
of 2.1-3.3% of the starting cell population. The ABCG2+ keratinocytes 
showed an undifferentiated phenotype of p63+, β1-integrin+, α6-integrin+, 
keratin14+, CD34-, CD71-, C-kit- and involucrin-. The ABCG2+ 
keratinocytes also showed extensive proliferation capacity in long term in 
vitro culture. In the reconstructed epidermis assay in vitro, these cells form 
stratified epidermis in an organotypic model. In clonal analysis, most of 
freshly isolated ABCG2+ keratinocytes (74%) form holoclones, while very 
few holoclones were observed in ABCG2-negative cells. As holoclones are 
widely accepted to be enriched in KSCs (Kobayashi, Rochat et al. 1993; 
Rochat, Kobayashi et al. 1994; Pellegrini, Dellambra et al. 2001; Claudinot, 
Nicolas et al. 2005), ABCG2 expression can be used to selectively isolate 
KSCs from human interfollicular skin. The long term durability of skin 
keratinocyte transplantation depends on the reserve and maintenance of stem 
cells in the skin grafts (Ronfard, Rives et al. 2000), therefore, ABCG2-positive 
keratinocytes can be used to enrich the KSC population for clinical application 






Chapter 5.  
 
ABCG2 identifies clonogenic keratinocytes in human 




5.1  INTRODUCTION 
It is widely accepted that skin epidermis is continuously renewed by epidermal 
stem cells (Jones, Harper et al. 1995; Li, Pouliot et al. 2004). Transplantation 
of epidermal stem cells, for example the usage of cultured epidermal 
autografts (CEA) for coverage of full-thickness skin wound or skin defect, has 
proven to restore epidermis structure and function (Compton, Gill et al. 1989). 
However little is known about the fate of epidermal stem cells engraftment. 
This study tries to answer the following questions: 
 
1. What is the growth potential of human epidermal stem cells after 
transplantation?  
2. How many epidermal stem cells are needed to maintain the self-
renewal of regenerated skin epidermis? 
3. Whether the enrichment of human epidermal stem cells in the 
epidermal grafts enhances the regeneration of skin epidermis?  
 
A precise investigation to cover these questions will allow the development of 
new therapeutics for epidermal stem cell transplantation. It is impossible to 
explore these questions in human beings because of the ethical restrictions. 
For the in vivo epidermal stem cell transplantation study, a few animal models 
have been developed, including mice, rats, rabbits, pigs and primates. 
Considering the cost and available techniques, nude mouse was used in this 





5.2  MATERIALS AND METHODS 
5.2.1  Human keratinocytes and fibroblasts preparation  
To prepare epidermal grafts for nude mice transplantation, fresh human skin 
keratinocytes and dermal fibroblast were isolated from normal adult skin 
samples. Skin samples were minced into 1cmX1cm squares, and incubated 
with 0.25% Dispase II at 4
0
C for 16 hours. The dermis tissue was manually 
separated from the epidermis with forceps, and the epidermis was finely 
minced. The keratinocytes were dissociated from the epidermis with 0.05% 
trypsin-0.02% EDTA solution at 37 
0
C for 20 minutes. Fresh keratinocytes 
were collected and incubated with anti-ABCG2 monoclonal antibody (1:25, 
5D3) or anti-a6 integrin antibody (1:100, GoH3) at 4
0
C for 30 minutes, 
washed with PBS twice, and re-suspended in 2%FBS/Hanks buffer solution. 
Fluorescence-activated cell sorting (FACS) was performed using a 
FACSadvantage SE (BD Biosciences, Mountain View, CA) cell sorter. The 
unsorted keratinocytes (served as blank control), ABCG2-positive cell, 
ABCG2-negative cell, a6-integrin-positive cell (served as positive control) 
were sorted out, and 50,000 cells from each cell population were seeded into 
one well of 6-well plate, in which the pig plasma gel was pre-seeded.  For 
each group, there were 4 wells, total 16 wells were prepared, and these 
epidermal grafts were transplanted onto 16 nude mice individually. The 
transplantation study was performed in duplicate.  
 
Human dermal fibroblasts were extracted from the dermal tissue of skin 
samples. Dermis tissue was minced and incubated in 0.1% collagenase for 2 
hours, dissociated fibroblasts were collected and seeded at 100,000 cells/cm2 
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using DEME supplemented with 10% FBS as the culture medium. The 
cultured medium was changed every 3 days, and sub-confluent fibroblasts 
culture was passaged every 6 days, and fibroblasts less than passage 4 was 
used for preparation of plasma gel.  
     
5.2.2  Preparation of cultured epidermal grafts using pig plasma. 
The protocol of preparation pig plasma gel was adopted from previous study 
(Llames, Del Rio et al. 2004). Fresh pig blood was extracted, and centrifuged 
at 4
0
C at 1500 rpm for 30 minutes, plasma was aliquoted and frozen at -80
0
C 
until use. One day before seeding human skin keratinocytes, pig plasma gel 
was prepared in 6-well plates. To prepare plasma gel in one 6-well plate, 10ml 
of pig plasma was mixed with 100,000 human skin dermal fibroblasts (0.5 
million/ml), and supplemented with 13ml of 0.9% NaCl solution. This mixture 
(total of 23ml) was pipetted up and down carefully, and supplemented with 
2ml of 1% CaCl2 solution 2ml. The final mixture was pipetted into 6-well 
plate at 4ml/plate, and the plate was moved into CO2 incubator at 37
0
C. The 
mixture was solidified in the incubator within 15 minutes. DMEM+10% FBS 
was added into each well at 3 ml/well. Keratinocytes were then seeded onto 
the plasma gel 16-24 hours later.  
 
5.2.3  Transplantation of epidermal grafts onto nude mice.   
Animal studies were carried out with the approval of the Singhealth 
Institutional Animal Care and Use Committee (IACUC). 6-8 weeks old nude 
athymic BALB/c nu/nu mice were used as skin graft recipients. They were 
purchased from ARC (Animal Resources Center, Perth, Western Australia), 
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housed and maintained in Singhealth Experimental Medical Center (SEMC) 
under specific pathogen-free conditions. All nude mice were kept at least 1 
week before experimental procedure.  
 
In a laminar flow cabinet, the nude mice were aseptically cleansed, 
anesthetized with ketamine (10mg/kg) and xylazine (2.4mg/kg) via 
intraperitoneal injection, and Toradol (3.5mg/kg) was injected as pain killer. A 
full-thickness skin wound with 3cm diameter was created on each back of the 
nude mouse, and each epidermal graft was manually lifted from 6-well plate 
and placed onto the back of the nude mouse. The cut off mouse skin during 
wound creation was frozen in liquid nitrogen and thawed for 5 cycles, this 
devitalized mouse skin was used as a biological wound dressing to protect and 
fix the skin grafts. To secure the grafts, normal gauzes were applied on top of 
the devitalized skin, and followed by several layers of standard dressing 
gauze. Antibiotics (Baytril®, Enrofloxacin, 120 mg/kg in drinking water) were 
given at the time of transplantation and were continued during next 5 days. 
After transplantation, the nude mouse was observed each day, and the wound 
dressings were changed every 2 days. The wound dressings were removed 
when the regenerated epidermis was robust enough, usually 3-4 weeks after 
transplantation. The nude mice were housed up to 20 weeks.  
 
5.2.4  Histological analysis 
The regenerated human epidermal grafts were biopsied at different time 
intervals, snap frozen in liquid nitrogen, and 8 µm frozen sections were 
prepared for hematoxylin-eosin staining.   
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 5.3  RESULTS.  
5.3.1  Preparation of human epidermal grafts for tranplantation 
Human epidermal grafts were prepared by seeding keratinocytes onto pig 
plasma gel (Materials and Methods, 5.2.2). After seeding cells for 3 days, 
keratinocytes colonies consists of 10-12 cells were observed (Fig.5.1); 
keratinocytes  reached confluence within 7-10 days, and a thin layer of 
keratinocytes with shiny appearance was observed (Fig.5.1).  
 
Fig.5.1. Preparation of human epidermal grafts. A: 3 days after skin keratinocytes 
were seeded onto pig plasma gel which incorporated skin dermal fibroblasts, noted 
fibroblasts (black arrow) were sparsely distributed with low seeding density, while 
keratinocytes formed 10-12 cells colonies (orange arrow). B: 7 days after 
keratinocytes were seeded, a thin layer of sub-confluent keratinocytes (light yellow) 
were observed on top of plasma gel. Scale bar: A, 50um; B, 40mm.  
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5.3.2  Transplantation of human epidermal grafts on nude mice 
For transplantation of human epidermal grafts, nude mice were anesthetized 
with ketamine (10mg/kg) and xylazine (2.4mg/kg) via intraperitoneal 
injection, the back skin was aseptically cleansed with iodine solution, and the 
skin transplantation area was marked in black (Fig.5.2).  A full-thickness skin 
wound with a diameter of 3cm was created at the center of back skin in each 
nude mouse, and the human epidermal graft was manually positioned to cover 
the skin wound (Fig.5.3). To protect and fix the skin grafts, also to keep 
moisture in wound bed, the cut-off mouse skin was frozen and thawed 
repeatedly 3 times; this devitalized mouse skin was then applied on top of skin 
grafts and being sutured (Fig.5.4).  The skin grafts take was assessed visually 
at least by 2 experienced veterinarians. Four nude mice were sacrificed 4 
weeks, 8 weeks, 12 weeks and 18 weeks after transplantation for histological 
analysis of the grafts. 
                         
Fig.5.2 Nu/nu mouse was anesthetized with ketamine (10mg/kg) and xylazine 
(2.4mg/kg) via intraperitoneal injection, the back skin was aseptically cleansed with 
iodine solution. The skin graft transplantation area was marked in black ink, 





                             
Fig.5.3 A full-thickness skin wound with a diameter of 3 cm was created at the center 
of back skin, and the human epidermal graft was manually positioned to cover the 






                     
Fig. 5.4 The cut off mouse skin was frozen in liquid nitrogen and thawed for 5 cycles, 
this devitalized skin was applied on top of the skin graft, to protect and fix the graft, 
also to keep moisture as well. 
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5.3.3  Engraftment of human epidermal grafts 
After grafting for 8 days, the wound dress was carefully removed, and the take 
of grafts were assessed. All grafts survived for the duration of transplantation, 
and no signs of necrosis were observed (Fig.5.5). The gross appearance of 
grafts changed from shiny (before grafting) to whitish color, which indicated 
the formation of stratum corneum on each grafts, induced by contact with the 
air. All the grafts from 4 groups showed no blister, and the take was excellent. 
However, the whitish layer of grafts in ABCG2-negative groups was observed 
to be much thinner than the other 3 groups.  
 
Fig.5.5 Macroscopic inspection of human epidermal grafts 8 days after 
transplantation onto nude mice. The whitish epidermis layer was observed in all 4 
groups (ABCG2+, ABCG2-, a6-integrin+ and control groups), which indicated the 
good take of grafts and beginning formation of epidermis. Note the white layer in 




5.3.4  Late engraftment of human epidermal grafts 
The nude mice of 4 experimental groups were maintained for up to 20 weeks, 
and skin biopsies were harvested from each group at 4, 8, 12 and 18 weeks 
and followed by histological staining. 4 weeks after grafting (Fig.5.6), the new 
formed human epidermis was observed in all 4 groups except ABCG2-
negative group, and pigmented dot areas were present in each graft, which was 
formed by passenger human melanocytes presented in the keratinocyte culture. 
In ABCG2-negative group, the pigmented epidermis was not formed; the skin 
wound was covered by regenerated mouse epidermis instead. 
 
Fig.5.6 Macroscopic inspection of human epidermal grafts 4 weeks after 
transplantation onto nude mice. Note pigmented dot areas in each grafts (resulting 
from passenger melanocytes from human epidermal grafts, except ABCG2-negative 
group) were present, which indicated successful engraftment. In ABCG2-negative 
group, human epidermis was not observed, and the skin wound was covered by 
regenerated mouse epidermis.  Scale bar: 20mm.   
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5.3.5  Histological analysis of human epidermal grafts 
The maturation and differentiation of grafts were analyzed by histological 
staining. 4 weeks after grafting (Fig. 5.7), the ABCG2+, a6-integrin+ and 
control groups epidermis were composed of several cell layers, including 
spinous and granular layers. The basal keratinocytes retained their cuboidal 
morphology, and the formation of a stratum corneum was in progress. At this 
time point after grafting, the new regenerated epidermis in these 3 groups 
comprised of 8-10 cell layers, and their thickness was similar. Note the loose 
dermis structure observed underneath the regenerated epidermis in these 
groups. In ABCG2-negative group, a well differentiated mouse epidermis 
consisted of 2-3 cell layers was observed, which indicated the replacement of 
grafts by mouse skin cells. 8 weeks after grafting (Fig.5.8), the newly formed 
epidermis within ABCG2+, a6-integrin+ and control groups were consisted of 
8-10 cell layers, with a thicker stratum corneum and much dense structure 
compared to 4 weeks after grafting; also a denser dermis structure was found 
within these 3 groups.   
 
12 weeks and 18 weeks after grafting (Fig.5 .9 and Fig. 5.10), well organized 
human epidermis with all histological cell layers were observed in ABCG2+, 
a6-integrin+ and control groups, which indicated the complete maturation and 
differentiation of epidermal cells. At 12 weeks, In ABCG2+ group, the 
epidermis consisted of 14-16 cell layers, which is significant thicker than those 
in control and a6-integrin groups (8-10 cell layers).  Note the presence of 
melanocyte (in brown color) within basal layer and formation of rete ridge 




Fig.5.7. Cross-section of the new epidermis formed by the human epidermal grafts on 
nude mice 4 weeks after transplantation. Well stratified human epidermis formed in 
ABCG2+ group; while mouse epidermis formed in ABCG2-negative group, which 
indicate the failed taking of human graft.  X20, Scale bar: 100 µm.  
 
 
Fig.5.8. Cross-section of the new epidermis formed by the human epidermal grafts on 
nude mice 8 weeks after transplantation. Note the compact and well stratified 
epidermis present in the ABCG2+ group. X20, Scale bar: 100 µm.   
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Fig.5.9 Cross-section of the new epidermis formed by the human epidermal grafts on 
nude mice 12 weeks after transplantation. Thick consolidated stratified epidermis was 
present in the ABCG2+ group. X20, Scale bar: 100 µm. 
 
Fig.5.10. Cross-section of the new epidermis formed by the human epidermal grafts 
on nude mice 18 weeks after transplantation. Well stratified epidermis was seen in 
ABCG2+ group, stratum corneum and rete ridge in basal layer was also present. X20, 
Scale bar: 100 µm.   
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5.4  Discussion 
 
In this study, we have shown that: 1) nude mice are reliable animal model for 
study of cultivated human epithelial grafts; 2) cultured human epithelial grafts 
can be successfully grafted onto full-thickness skin wounds on nude mice, and 
these grafts formed a well differentiated epidermis, the regenerated epidermis 
can be maintained for more than 18 weeks in vivo; 3) the cultured human 
epithelial grafts derived from ABCG2+ keratinocytes can be grafted onto full-
thickness skin wound, and formed new epidermis, as well as in the control 
group and a6-integrin+ group; but for ABCG2-negative group, the grafts 
failed to survive; 4) In long term observation after transplantation, the 
regenerated epidermis derived from  ABCG2+ keratinocytes showed thick 
epidermal cell layers, including stratum corneum and rete ridge in the basal 
layer.  
 
Cultured epithelial grafts have been developed by culturing keratinocytes in 
petri dish, on fibrin matrices or on human/pig plasma (Meana, Iglesias et al. 
1998; Ronfard, Rives et al. 2000; Del Rio, Larcher et al. 2002). The advantage 
of using fibrin matrice is that it retains the “stemness” of keratinocyte stem 
cells, which is most important for skin transplantation and regeneration. In this 
study, the pig plasma was used to support keratinocyte growth and served as a 
dermal scaffold for human fibroblasts. The long term take of cultured human 
epidermal grafts in nude mice suggests this protocol allows functional analysis 
of epidermal stem cells in vivo. The presence of cytokines and growth factors 




In this study, the human grafts derived from ABCG2+, a6-integrin+ and 
control keratinocytes showed excellent take and survived up to 20 weeks. 
After 12 weeks, the epidermis derived from ABCG2+ keratinocytes showed 
thicker epidermis cell layers than in the control and α6-integrin+ group. This 
difference might be related to the different proportions of clonogenic cells 
present in the deriving keratinocytes, as our previous results suggested high 
proprtions of clonogenic cells within ABCG2+ population. As clonal analysis 
is the only an indirect way to investigate epidermal stem cell portions in the 
regenerated epidermis, clonal analysis should be performed to monitor the 
stem cell fate and final conversion after transplantation.  On the other hand, 
high proportion of clonogenic cells or stem cells within cultured epithelial 
grafts remain the best criteria for epithelial grafts, and it might be surmised 
that the more stem cells within a graft, the more chances the graft will survive 
in the long-term following transplantation. 








Chapter 6.   
 
Conclusions and future clinical applicagtions  
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6.1  A NOVEL CULTIVATION MEDIUM FOR OF EPIDERMAL 
STEM CELLS 
The most well-known keratinocyte culture methods are the methods developed 
by Rheinwald & Green in 1975 and by Boyce & Ham in 1983 (Rheinwald and 
Green 1975; Boyce and Ham 1983). Both methods have been widely used, but 
they have their deficiencies. My research is to create a novel culture system 
(medium and matrix) for human epidermal stem cell with safety in mind for 
future clinical applications.  
 
The Rheinwald-Green protocol is characterized by use of mouse mesenchymal 
fibroblasts (3T3-J2) as feeder layer. With the presence of 3T3 feeder layer, the 
attachment and proliferation of skin dermal fibroblasts were inhibited, which 
allowed selected culture of keratinocytes alone in this method. Human skin 
keratinocytes can be maintained for more than 25 passages on 3T3 feeder 
layer (Barrandon and Green 1985). Most importantly, clonal keratinocyte 
growth and stem cell preservation (measured by the presence of holoclones) 
were only observed in the presence of 3T3 feeder layer (Pellegrini, De Luca et 
al. 2007). Using Rheinwald & Green’s method, regenerated epithelium was 
also successfully applied in treatment of severe burns, congenital skin 
anomalies, oral mucosa regeneration and restoration of ocular surface 
epithelium (Gallico, O'Connor et al. 1984; Ronfard, Rives et al. 2000; 
Pellegrini, De Luca et al. 2007). However, as 3T3 cells proliferate more 
rapidly than keratinocytes, their proliferation ability has to be stopped by 
exposing them to γ-irradiation or anticancer drug (Mitomycin-C). To culture 
human keratinocytes for severe burn and skin defect patients, the 3T3 
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fibroblasts have to be simultaneously and constantly maintained with 
keratinocyte cultures. The drawback in Rheinwald & Green’s method which 
relies on the murine feeder layer and fetal bovine serum is that it carries the 
risk of exposing cell culture to animal pathologies. In addition, it also 
introduces immune stimulating agents, such as N-glycolylneuraminic acid 
(Neu5Ac) (Martin, Muotri et al. 2005), into the culture system. 
 
The Boyce-Ham method was developed in 1983 (Boyce and Ham 1983). It is 
a low calcium culture medium based on the MCDB153 medium, without fetal 
bovine serum, but supplemented with several growth factors and bovine 
pituitary extract (BPE). As there is a great concern with bovine spongiform 
encephalopathy and Creutzfeldt-Jakob disease, BPE was later replaced by 
various human recombinant growth factor cocktails. The Boyce-Ham method 
does not use the 3T3 feeder layer and it has been marketed in the form of a 
keratinocyte culture kit by certain commercial companies. However, 
keratinocytes can only be maintained in these serum free medium for a few 
limited passages, and clonal growth of keratinocytes were rarely observed. To 
date, there is no serum-free, feeder-free and fully defined medium which can 
support epithelial cells clonogenic expansion at a low cell seeding density.  
 
To develop a novel serum free and feeder free culture media for skin 
keratinocytes, I used fibronectin to replace the 3T3 feeder layer in Rheinwald 
and Green’s protocol. This was used in combination with B27, which is a kind 
of culture supplement for neuronal cells,  to replace the fetal bovine serum, as 
B27 has been proven to be effective for maintenance of pluripotent stem cells 
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in a serum-free medium (Brewer 1995). (Yokoo, Yamagami et al. 2005; Yao, 
Chen et al. 2006; Yokoo, Yamagami et al. 2008),  
 
Combining fibronectin and B27, we have shown that that human primary 
keratinocytes can be established and serially expanded using this novel culture 
system. Keratinocyte colonies can be expanded from single cells in this culture 
medium, and the cells maintained their undifferentiated phenotype and can be 
serially cultivated for more than 10 passages. In addition, keratinocytes 
maintained in this culture medium can be induced to differentiate into a fully 
stratified skin-equivalent epidermis in vitro. This study has shown that this 
novel culture system might be a safer and better alternative to the existing 
protocols, especially for future therapeutic applications. Further in vivo studies 
are needed to fully characterize this culture system and test the safety 
concerns. To avoid the inclusion of extra variant factors, routine keratinocyte 
culture was maintained using Green’s FAD medium and 3T3 feeder layers for 
the other chapters of this project.   
 
6.2  ABCG2 IDENTIFICATION OF HUMAN INTERFOLLICULAR 
EPIDERMAL STEM CELLS  
Epidermal stem cells have been identified in different sites in adult epidermis: 
bulge region of hair follicle, basal layer of epidermis and sebaceous 
gland(Ghazizadeh and Taichman 2001). As epidermal stem cells of bulge 
region and sebaceous gland are located in easily identifiable and distinct 
anatomical sites, they are well studied and understood. In contrast, epidermal 
stem cells within the interfollicular epidermis have been studied only through 
122 
 
indirect assays, and there are no specific markers capable of isolating and 
identifying stem cells at the single cell level (Kaur 2006). 
 
Different methods to isolate epidermal stem cells have been proposed, 
including (1) α6-bright/CD71-dim human keratinocytes (Li, Simmons et al. 
1998; Terunuma, Kapoor et al. 2007), (2) rapid adhesion of cells to collagen 
IV (Bickenbach and Chism 1998), (3) DNA label-retaining cells representing 
slow-cycling cells (Bickenbach 1981; Kiel, He et al. 2007) and (4) side 
population cells that efflux Hoechst 33342 fluorescent dye (Terunuma, 
Jackson et al. 2003; Triel, Vestergaard et al. 2004). 
 
The combination of high α6 integrin expression (α6bri) and low expression of 
the transferrin receptor (CD71dim) is perhaps the most accepted epidermal 
stem cell identification protocol to date (Li, Simmons et al. 1998). In mouse 
skin, α6briCD71dim cells are relatively quiescent in vivo with high long-term 
proliferative capacity. In fresh isolated keratinocytes, 1.4% of total isolated 
keratinocytes are both α6briCD71dim and label-retaining cells (Tani, Morris 
et al. 2000). In human skin, the α6briCD71dim population has been shown to 
contain small cells with a high nuclear to cytoplasmic ratio, capable of 
producing a high number of large colonies. These cells form skin equivalents, 
and a stratified and thick epidermis in vivo, while skin equivalents from 
α6briCD71bri cells produced a thin and less well differentiated epidermis 
(Kim, Cho et al. 2004). 
 
The aims of my thesis are to elucidate the role of ABCG2 in the identification 
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of human epidermal stem cells both in vitro and in vivo models. I have shown 
that the ABCG2 transporter was mainly localized in the basal layer of human 
interfollicular epidermis, not in the suprabasal layer. The ABCG2-positive 
keratinocytes made up 2.1-3.3% of the total epidermal keratinocytes. These 
cells exhibited a molecular profile that was p63-positive, β1-integrin-positive, 
α6-integrin-positive, keratin14-positive, CD34-negative, CD71-negative, C-
kit-negative and involucrin-negative, which was similar to that of 
α6briCD71dim keratinocytes. The ABCG2-positive keratinocytes showed 
significantly higher colony forming efficiency than ABCG2-negative 
keratinocytes. The ABCG2-positive keratinocytes also showed extensive 
proliferation capacity in long-term in-vitro culture, and most of the freshly 
isolated ABCG2-positive keratinocytes formed holoclones. Moreover, they 
formed pluristratified epidermis in an organotypic culture model. These data 
indicate that ABCG2 is exclusively expressed by basal keratinocytes in human 
interfollicular epidermis and this population of cells possesses keratinocyte 
stem cell properties, suggesting that ABCG2 might be a useful marker for 
enriching keratinocyte stem cells in human interfollicular epidermis. In our in 
vivo study, we have shown that cultured human epithelial grafts derived from 
ABCG2+ keratinocytes can be grafted onto full-thickness skin wound, and 
formed new epidermis. The ABCG2-negative epithelial grafts failed to 
survive. In our long term observations after transplantation, the regenerated 
epidermis derived from ABCG2+ keratinocytes showed thick epidermal cell 
layers. This difference might relate to the different proportions of clonogenic 
cells present in the seeded keratinocytes. As clonal analysis is the only and 
direct way to investigate epidermal stem cell proportions in the regenerated 
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epidermis, clonal analysis should be performed to monitor the stem cell fate 
and final conversion after transplantation.  Due to the timeline of this project, 
clonal analysis was not performed.  
 
6.3 POTENTIAL APPLICATIONS OF EPIDERMAL STEM CELLS 
6.3.1  Novel composite skin substitute with enriched epidermal stem cells 
Annually, the SGH Burns Centre sees up to 200 burns patients, excluding 
patients with traumatic skin loss, who will require skin grafts. Methods for 
handling such injuries have changed in recent decades and increasingly 
aggressive surgical approach with early tangential excision and wound closure 
is being applied. Surgeons now face the challenge of excising and grafting 
larger burns with limited autograft availability. In such cases, it is necessary to 
find alternatives to conventional split-thickness skin (STSG) autograft. While 
cadaveric skin allograft has been effective for short term physiological wound 
coverage, it is only temporary coverage because of immunological factors, 
which result in tissue rejection, usually after 2 to 3 weeks.  In addition, there 
are also problems of limited human donors and hence supply of these 
allografts. The SGH Skin Bank has had to import such tissues from overseas 
during major burns disasters.  Therefore, there is an urgent and overwhelming 
need to develop an autologous tissue-engineered (TE) skin replacement which 
can be produced efficiently, especially for patients with extensive burns.  
 
The other group of patients in direct need for skin replacement is for chronic 
venous and diabetic ulcers. In Singapore, 10% of our population has diabetes 
mellitus and many of these patients suffer full thickness lower extremity ulcers 
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which are difficult to heal and often lead to considerable morbidity. Despite 
the best care given, complete healing of these ulcers often remains an elusive 
goal. The need for a proper TE skin replacement as an alternative to 
conventional therapy is urgently needed. 
 
Currently, bioengineered skin grafts are increasingly available for use in burns 






.  These 
are allogeneic cell-based skin substitutes (either monolayer or bilayer), and 
studies have shown that they were more effective in wound healing than 
standard care. They are very expensive due to the time and expense of 
preparation and the short shelf-life of the products, and thus their use is 
restricted to hard-to-heal wound cases and small wound areas  (Falanga and 
Sabolinski 1999; Curran and Plosker 2002; Marston, Hanft et al. 2003; 
Edmonds 2009). One of the most advanced skin replacement used clinically is 
the Cincinnati skin substitute, or Permaderm
TM
 which comprises autologous 
keratinocytes (epidermis) and fibroblasts grafted into reconstructed skin with 
bovine collagen (dermis). But this bilayered product is devoid of skin 
appendages such as sensory receptors, hair follicles, sweat glands, sebaceous 
glands, etc.; and cells such as melanocytes, immune cells and endothelial cells. 
Now that ABCG2 can effectively sort out epidermal stem cell population as 
demonstrated in this thesis, the possibility of producing the “ideal” bilayered 
skin equivalent with enriched epidermal stem cells seeded onto a “neo-dermis” 
incorporated with autologous skin fibroblasts or mesenchymal cells is 
enhanced. The presence of enriched epidermal stem cells in such a skin 
equivalent offer hope to overcome the limitations of current skin replacement, 
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as it has been proven that by placing these cells in a suitable 
microenvironment, appendages such as hair, epidermis and sebaceous glands 
can be formed (Richardson, Arnott et al. 2005).  
 
6.3.2.  Reprogramming of iPSCs using epidermal stem cells 
The induced pluripotent stem cell (iPSC) technology was developed by Shinya 
Yamanaka in 2006, by forced expression of four transcription factors c-Myc, 
Klf4, Oct4, and Sox2; or Lin28, Nanog, Oct4 and Sox2. iPSCs are 
reprogrammed from somatic cells; have similar properties to embryonic stem 
(ES) cells, in terms of self-renewal, proliferation capacity, gene expression, 
stem cells phenotype, epigenetic state and differentiation capacity. iPSCs have 
a remarkable impact on the field of developmental biology and regenerative 
medicine. As iPSCs share similar development potential as embryonic stem 
cells (ESCs), they therefore hold great promise as an alternative source of 
pluripotent stem cells for clinical use, while circumventing the ethical 
controversies and immunological issues associated with traditional ESCs 
research. iPSC technology has successfully been used for setting up in vitro 
cellular model for certain diseases, including Parkinson’s disease and Long 
QT syndrome. In addition, iPSCs could be used for future cell and tissue 
therapy.  
 
To date, the most widely used method of reprogramming iPSCs is to transduce 
skin fibroblasts with viruses (retroviruses or lentiviruses), which harbor the 
four reprogramming factors. This viral reprogramming method has slow 
kinetics and low efficiency (0.01 – 0.1%). These viruses integrate randomly 
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into the genome of the host cells and could interrupt endogenous genes to 
cause insertional mutagenesis. Although the integrated reprogramming factors 
seem to be silenced at the end of reprogramming, leaky expression of 
reprogramming factors may exist to restrict the differentiation capacity of the 
reprogrammed cells (Okita and Yamanaka, 2010), or reactivation of 
reprogramming factors could happen to result in tumorigenicity (Okita et al., 
2007). All these problems hinder the use of viral systems-derived iPSCs in 
clinical applications. 
 
Keratinocytes were proven to be reprogrammed within shorter time frames 
and with higher efficiencies than fibroblasts (more than 100 fold than 
fibroblasts). One possible reason is that there are epidermal stem cells within 
keratinocyte culture. It was reported that keratinocytes express higher levels of 
KLF4 and C-Myc, which means they are closer to embryonic stem cells in 
terms of stem cell gene expression. This might be the reason why 
keratinocytes command shorter reprogramming time and lesser transcription 
factors than fibroblasts. 
 
The intrinsic properties of a somatic cell determine its potential in the 
generation of iPSCs cells, but cell accessibility also affects the practicality in 
clinical and research settings. Invasive intervention for retrieval of somatic 
cells is a deterrent that usually results in low patient compliance. Cells that 
possess high reprogramming efficiency might be difficult for retrieval and vice 
versa, hence, a balance between both factors must be considered. As skin 
keratinocytes are easy to harvest from skin samples, iPSCs can be easily 
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reprogrammed from sorted epidermal stem cells, although future work will be 
needed to optimize the protocol.  
 
Reprogramming of ABCG2+ epidermal stem cells to iPSCs will provide a 
valuable experimental model for investigating the cellular reprogramming 
mechanism, setting up cellular disease model and has tremendous potential for 
future cellular therapy and tissue regeneration. They are the exciting 
challenges for optimizing the knowledge desired from these detailed studies 
on ABCG2+ epidermal stem cells. 





Adamski, D., J. F. Mayol, et al. (2007). "Effects of Hoechst 33342 on C2C12 
and PC12 cell differentiation." FEBS Lett 581(16): 3076-3080. 
Ainscough, S. L., Z. Barnard, et al. (2006). "Vitronectin supports migratory 
responses of corneal epithelial cells to substrate bound IGF-I and HGF, 
and facilitates serum-free cultivation." Exp Eye Res 83(6): 1505-1514. 
Allikmets, R., L. M. Schriml, et al. (1998). "A human placenta-specific ATP-
binding cassette gene (ABCP) on chromosome 4q22 that is involved in 
multidrug resistance." Cancer Res 58(23): 5337-5339. 
Alonso, L. and E. Fuchs (2003). "Stem cells of the skin epithelium." Proc Natl 
Acad Sci U S A 100 Suppl 1: 11830-11835. 
Annilo, T., Z. Q. Chen, et al. (2006). "Evolution of the vertebrate ABC gene 
family: analysis of gene birth and death." Genomics 88(1): 1-11. 
Apati, A., T. I. Orban, et al. (2008). "High level functional expression of the 
ABCG2 multidrug transporter in undifferentiated human embryonic 
stem cells." Biochim Biophys Acta 1778(12): 2700-2709. 
Asplund, A., Z. Guo, et al. (2001). "Mosaic pattern of maternal and paternal 
keratinocyte clones in normal human epidermis revealed by analysis of 
X-chromosome inactivation." J Invest Dermatol 117(1): 128-131. 
Barrandon, Y. and H. Green (1985). "Cell size as a determinant of the clone-
forming ability of human keratinocytes." Proc Natl Acad Sci U S A 
82(16): 5390-5394. 
Barrandon, Y. and H. Green (1987). "Three clonal types of keratinocyte with 
different capacities for multiplication." Proc Natl Acad Sci U S A 
84(8): 2302-2306. 
Barry, F. P. and J. M. Murphy (2004). "Mesenchymal stem cells: clinical 
applications and biological characterization." Int J Biochem Cell Biol 
36(4): 568-584. 
Benabdelhak, H., S. Kiontke, et al. (2003). "A specific interaction between the 
NBD of the ABC-transporter HlyB and a C-terminal fragment of its 
transport substrate haemolysin A." J Mol Biol 327(5): 1169-1179. 
Benitah, S. A., M. Frye, et al. (2005). "Stem cell depletion through epidermal 
deletion of Rac1." Science 309(5736): 933-935. 
Bhattacharya, S., A. Das, et al. (2007). "Maintenance of retinal stem cells by 
Abcg2 is regulated by notch signaling." J Cell Sci 120(Pt 15): 2652-
2662. 
Bickenbach, J. R. (1981). "Identification and behavior of label-retaining cells 
in oral mucosa and skin." J Dent Res 60 Spec No C: 1611-1620. 
Bickenbach, J. R. and E. Chism (1998). "Selection and extended growth of 
murine epidermal stem cells in culture." Exp Cell Res 244(1): 184-195. 
Biedermann, T., L. Pontiggia, et al. (2010). "Human eccrine sweat gland cells 
can reconstitute a stratified epidermis." J Invest Dermatol 130(8): 
1996-2009. 
Blanpain, C., W. E. Lowry, et al. (2004). "Self-renewal, multipotency, and the 
existence of two cell populations within an epithelial stem cell niche." 
Cell 118(5): 635-648. 
130 
 
Boyce, S. T. and R. G. Ham (1983). "Calcium-regulated differentiation of 
normal human epidermal keratinocytes in chemically defined clonal 
culture and serum-free serial culture." J Invest Dermatol 81(1 Suppl): 
33s-40s. 
Braun, K. M., C. Niemann, et al. (2003). "Manipulation of stem cell 
proliferation and lineage commitment: visualisation of label-retaining 
cells in wholemounts of mouse epidermis." Development 130(21): 
5241-5255. 
Brewer, G. J. (1995). "Serum-free B27/neurobasal medium supports 
differentiated growth of neurons from the striatum, substantia nigra, 
septum, cerebral cortex, cerebellum, and dentate gyrus." J Neurosci 
Res 42(5): 674-683. 
Brouard, M. and Y. Barrandon (2003). "Controlling skin morphogenesis: hope 
and despair." Curr Opin Biotechnol 14(5): 520-525. 
Brown, J., M. F. Greaves, et al. (1991). "The gene encoding the stem cell 
antigen, CD34, is conserved in mouse and expressed in haemopoietic 
progenitor cell lines, brain, and embryonic fibroblasts." Int Immunol 
3(2): 175-184. 
Budak, M. T., O. S. Alpdogan, et al. (2005). "Ocular surface epithelia contain 
ABCG2-dependent side population cells exhibiting features associated 
with stem cells." J Cell Sci 118(Pt 8): 1715-1724. 
Chapel, A., J. M. Bertho, et al. (2003). "Mesenchymal stem cells home to 
injured tissues when co-infused with hematopoietic cells to treat a 
radiation-induced multi-organ failure syndrome." J Gene Med 5(12): 
1028-1038. 
Chen, G., D. R. Gulbranson, et al. (2011). "Chemically defined conditions for 
human iPSC derivation and culture." Nat Methods 8(5): 424-429. 
Chen, M., N. Kasahara, et al. (2002). "Restoration of type VII collagen 
expression and function in dystrophic epidermolysis bullosa." Nat 
Genet 32(4): 670-675. 
Chen, Z., F. Liu, et al. (2010). "Suppression of ABCG2 inhibits cancer cell 
proliferation." Int J Cancer 126(4): 841-851. 
Clarke, R. B., K. Spence, et al. (2005). "A putative human breast stem cell 
population is enriched for steroid receptor-positive cells." Dev Biol 
277(2): 443-456. 
Claudinot, S., M. Nicolas, et al. (2005). "Long-term renewal of hair follicles 
from clonogenic multipotent stem cells." Proc Natl Acad Sci U S A 
102(41): 14677-14682. 
Clayton, E., D. P. Doupe, et al. (2007). "A single type of progenitor cell 
maintains normal epidermis." Nature 446(7132): 185-189. 
Clayton, H., I. Titley, et al. (2004). "Growth and differentiation of 
progenitor/stem cells derived from the human mammary gland." Exp 
Cell Res 297(2): 444-460. 
Compton, C. C., J. M. Gill, et al. (1989). "Skin regenerated from cultured 
epithelial autografts on full-thickness burn wounds from 6 days to 5 
years after grafting. A light, electron microscopic and 
immunohistochemical study." Lab Invest 60(5): 600-612. 
Cotsarelis, G. (2006). "Epithelial stem cells: a folliculocentric view." J Invest 
Dermatol 126(7): 1459-1468. 
131 
 
Cotsarelis, G., T. T. Sun, et al. (1990). "Label-retaining cells reside in the 
bulge area of pilosebaceous unit: implications for follicular stem cells, 
hair cycle, and skin carcinogenesis." Cell 61(7): 1329-1337. 
Crigler, L., A. Kazhanie, et al. (2007). "Isolation of a mesenchymal cell 
population from murine dermis that contains progenitors of multiple 
cell lineages." FASEB J 21(9): 2050-2063. 
Croagh, D., W. A. Phillips, et al. (2007). "Identification of candidate murine 
esophageal stem cells using a combination of cell kinetic studies and 
cell surface markers." Stem Cells 25(2): 313-318. 
Curran, M. P. and G. L. Plosker (2002). "Bilayered bioengineered skin 
substitute (Apligraf): a review of its use in the treatment of venous leg 
ulcers and diabetic foot ulcers." BioDrugs 16(6): 439-455. 
Dawson, R. A., N. J. Goberdhan, et al. (1996). "Influence of extracellular 
matrix proteins on human keratinocyte attachment, proliferation and 
transfer to a dermal wound model." Burns 22(2): 93-100. 
Dawson, R. A., Z. Upton, et al. (2006). "Preparation of cultured skin for 
transplantation using insulin-like growth factor I in conjunction with 
insulin-like growth factor binding protein 5, epidermal growth factor, 
and vitronectin." Transplantation 81(12): 1668-1676. 
de Paiva, C. S., Z. Chen, et al. (2005). "ABCG2 transporter identifies a 
population of clonogenic human limbal epithelial cells." Stem Cells 
23(1): 63-73. 
Dean, M., A. Rzhetsky, et al. (2001). "The human ATP-binding cassette 
(ABC) transporter superfamily." Genome Res 11(7): 1156-1166. 
Del Rio, M., F. Larcher, et al. (2002). "A preclinical model for the analysis of 
genetically modified human skin in vivo." Hum Gene Ther 13(8): 959-
968. 
DePianto, D. and P. A. Coulombe (2004). "Intermediate filaments and tissue 
repair." Exp Cell Res 301(1): 68-76. 
Diestra, J. E., G. L. Scheffer, et al. (2002). "Frequent expression of the multi-
drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in 
human tumours detected by the BXP-21 monoclonal antibody in 
paraffin-embedded material." J Pathol 198(2): 213-219. 
Digirolamo, C. M., D. Stokes, et al. (1999). "Propagation and senescence of 
human marrow stromal cells in culture: a simple colony-forming assay 
identifies samples with the greatest potential to propagate and 
differentiate." Br J Haematol 107(2): 275-281. 
Doyle, L. A., W. Yang, et al. (1998). "A multidrug resistance transporter from 
human MCF-7 breast cancer cells." Proc Natl Acad Sci U S A 95(26): 
15665-15670. 
Edmonds, M. (2009). "Apligraf in the treatment of neuropathic diabetic foot 
ulcers." Int J Low Extrem Wounds 8(1): 11-18. 
Falanga, V. and M. Sabolinski (1999). "A bilayered living skin construct 
(APLIGRAF) accelerates complete closure of hard-to-heal venous 
ulcers." Wound Repair Regen 7(4): 201-207. 
Fernandes, K. J., J. G. Toma, et al. (2008). "Multipotent skin-derived 
precursors: adult neural crest-related precursors with therapeutic 
potential." Philos Trans R Soc Lond B Biol Sci 363(1489): 185-198. 
132 
 
Fetsch, P. A., A. Abati, et al. (2006). "Localization of the ABCG2 
mitoxantrone resistance-associated protein in normal tissues." Cancer 
Lett 235(1): 84-92. 
Freitas, C. S. and S. R. Dalmau (2006). "Multiple sources of non-embryonic 
multipotent stem cells: processed lipoaspirates and dermis as 
promising alternatives to bone-marrow-derived cell therapies." Cell 
Tissue Res 325(3): 403-411. 
Gallico, G. G., 3rd, N. E. O'Connor, et al. (1984). "Permanent coverage of 
large burn wounds with autologous cultured human epithelium." N 
Engl J Med 311(7): 448-451. 
Gharzi, A., A. J. Reynolds, et al. (2003). "Plasticity of hair follicle dermal 
cells in wound healing and induction." Exp Dermatol 12(2): 126-136. 
Ghazizadeh, S. and L. B. Taichman (2001). "Multiple classes of stem cells in 
cutaneous epithelium: a lineage analysis of adult mouse skin." EMBO 
J 20(6): 1215-1222. 
Goodell, M. A., K. Brose, et al. (1996). "Isolation and functional properties of 
murine hematopoietic stem cells that are replicating in vivo." J Exp 
Med 183(4): 1797-1806. 
Gurtner, G. C., S. Werner, et al. (2008). "Wound repair and regeneration." 
Nature 453(7193): 314-321. 
Haegebarth, A. and H. Clevers (2009). "Wnt signaling, lgr5, and stem cells in 
the intestine and skin." Am J Pathol 174(3): 715-721. 
Haraguchi, N., T. Utsunomiya, et al. (2006). "Characterization of a side 
population of cancer cells from human gastrointestinal system." Stem 
Cells 24(3): 506-513. 
Higgins, C. F. (1992). "ABC transporters: from microorganisms to man." 
Annu Rev Cell Biol 8: 67-113. 
Hinz, B. (2007). "Formation and function of the myofibroblast during tissue 
repair." J Invest Dermatol 127(3): 526-537. 
Hirschmann-Jax, C., A. E. Foster, et al. (2004). "A distinct "side population" 
of cells with high drug efflux capacity in human tumor cells." Proc 
Natl Acad Sci U S A 101(39): 14228-14233. 
Hoeller, D., B. Huppertz, et al. (2001). "An improved and rapid method to 
construct skin equivalents from human hair follicles and fibroblasts." 
Exp Dermatol 10(4): 264-271. 
Hollier, B., D. G. Harkin, et al. (2005). "Responses of keratinocytes to 
substrate-bound vitronectin: growth factor complexes." Exp Cell Res 
305(1): 221-232. 
Hoogduijn, M. J., E. Gorjup, et al. (2006). "Comparative characterization of 
hair follicle dermal stem cells and bone marrow mesenchymal stem 
cells." Stem Cells Dev 15(1): 49-60. 
Horwitz, E. M., P. L. Gordon, et al. (2002). "Isolated allogeneic bone marrow-
derived mesenchymal cells engraft and stimulate growth in children 
with osteogenesis imperfecta: Implications for cell therapy of bone." 
Proc Natl Acad Sci U S A 99(13): 8932-8937. 
Hynes, R. O. (1992). "Integrins: versatility, modulation, and signaling in cell 
adhesion." Cell 69(1): 11-25. 
Ito, M., Y. Liu, et al. (2005). "Stem cells in the hair follicle bulge contribute to 




Jensen, K. B., C. A. Collins, et al. (2009). "Lrig1 expression defines a distinct 
multipotent stem cell population in mammalian epidermis." Cell Stem 
Cell 4(5): 427-439. 
Jensen, K. B. and F. M. Watt (2006). "Single-cell expression profiling of 
human epidermal stem and transit-amplifying cells: Lrig1 is a regulator 
of stem cell quiescence." Proc Natl Acad Sci U S A 103(32): 11958-
11963. 
Jensen, U. B., S. Lowell, et al. (1999). "The spatial relationship between stem 
cells and their progeny in the basal layer of human epidermis: a new 
view based on whole-mount labelling and lineage analysis." 
Development 126(11): 2409-2418. 
Jin, Y., Z. Q. Bin, et al. (2009). "ABCG2 is related with the grade of glioma 
and resistance to mitoxantone, a chemotherapeutic drug for glioma." J 
Cancer Res Clin Oncol 135(10): 1369-1376. 
Jones, P. H., S. Harper, et al. (1995). "Stem cell patterning and fate in human 
epidermis." Cell 80(1): 83-93. 
Jones, P. H., B. D. Simons, et al. (2007). "Sic transit gloria: farewell to the 
epidermal transit amplifying cell?" Cell Stem Cell 1(4): 371-381. 
Jones, P. H. and F. M. Watt (1993). "Separation of human epidermal stem 
cells from transit amplifying cells on the basis of differences in 
integrin function and expression." Cell 73(4): 713-724. 
Jonker, J. W., M. Buitelaar, et al. (2002). "The breast cancer resistance protein 
protects against a major chlorophyll-derived dietary phototoxin and 
protoporphyria." Proc Natl Acad Sci U S A 99(24): 15649-15654. 
Jonker, J. W., J. Freeman, et al. (2005). "Contribution of the ABC transporters 
Bcrp1 and Mdr1a/1b to the side population phenotype in mammary 
gland and bone marrow of mice." Stem Cells 23(8): 1059-1065. 
Kaur, P. (2006). "Interfollicular epidermal stem cells: identification, 
challenges, potential." J Invest Dermatol 126(7): 1450-1458. 
Kiel, M. J., S. He, et al. (2007). "Haematopoietic stem cells do not 
asymmetrically segregate chromosomes or retain BrdU." Nature 
449(7159): 238-242. 
Kim, D. S., H. J. Cho, et al. (2004). "Isolation of human epidermal stem cells 
by adherence and the reconstruction of skin equivalents." Cell Mol 
Life Sci 61(21): 2774-2781. 
Kim, M., H. Turnquist, et al. (2002). "The multidrug resistance transporter 
ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 
and is overexpressed in hematopoietic stem cells." Clin Cancer Res 
8(1): 22-28. 
Kisseleva, T. and D. A. Brenner (2008). "Mechanisms of fibrogenesis." Exp 
Biol Med (Maywood) 233(2): 109-122. 
Kobayashi, K., A. Rochat, et al. (1993). "Segregation of keratinocyte colony-
forming cells in the bulge of the rat vibrissa." Proc Natl Acad Sci U S 
A 90(15): 7391-7395. 
Koc, O. N., J. Day, et al. (2002). "Allogeneic mesenchymal stem cell infusion 
for treatment of metachromatic leukodystrophy (MLD) and Hurler 
syndrome (MPS-IH)." Bone Marrow Transplant 30(4): 215-222. 
Koc, O. N., S. L. Gerson, et al. (2000). "Rapid hematopoietic recovery after 
coinfusion of autologous-blood stem cells and culture-expanded 
134 
 
marrow mesenchymal stem cells in advanced breast cancer patients 
receiving high-dose chemotherapy." J Clin Oncol 18(2): 307-316. 
Kolodka, T. M., J. A. Garlick, et al. (1998). "Evidence for keratinocyte stem 
cells in vitro: long term engraftment and persistence of transgene 
expression from retrovirus-transduced keratinocytes." Proc Natl Acad 
Sci U S A 95(8): 4356-4361. 
Krause, D. S., T. Ito, et al. (1994). "Characterization of murine CD34, a 
marker for hematopoietic progenitor and stem cells." Blood 84(3): 
691-701. 
Krishnamurthy, P., D. D. Ross, et al. (2004). "The stem cell marker 
Bcrp/ABCG2 enhances hypoxic cell survival through interactions with 
heme." J Biol Chem 279(23): 24218-24225. 
Krishnan, S., S. Lakshmanan, et al. (2010). "The role of signaling pathways in 
the expansion of corneal epithelial cells in serum-free B27 
supplemented medium." Mol Vis 16: 1169-1177. 
Kruger, J. A., C. D. Kaplan, et al. (2006). "Characterization of stem cell-like 
cancer cells in immune-competent mice." Blood 108(12): 3906-3912. 
Kubo, M., M. Kan, et al. (1987). "Effects of extracellular matrices on human 
keratinocyte adhesion and growth and on its secretion and deposition 
of fibronectin in culture." J Invest Dermatol 88(5): 594-601. 
Lajtha, L. G. (1979). "Stem cell concepts." Differentiation 14(1-2): 23-34. 
Larderet, G., N. O. Fortunel, et al. (2006). "Human side population 
keratinocytes exhibit long-term proliferative potential and a specific 
gene expression profile and can form a pluristratified epidermis." Stem 
Cells 24(4): 965-974. 
Levy, V., C. Lindon, et al. (2005). "Distinct stem cell populations regenerate 
the follicle and interfollicular epidermis." Dev Cell 9(6): 855-861. 
Li, A., N. Pouliot, et al. (2004). "Extensive tissue-regenerative capacity of 
neonatal human keratinocyte stem cells and their progeny." J Clin 
Invest 113(3): 390-400. 
Li, A., P. J. Simmons, et al. (1998). "Identification and isolation of candidate 
human keratinocyte stem cells based on cell surface phenotype." Proc 
Natl Acad Sci U S A 95(7): 3902-3907. 
Liu, Y., S. Lyle, et al. (2003). "Keratin 15 promoter targets putative epithelial 
stem cells in the hair follicle bulge." J Invest Dermatol 121(5): 963-
968. 
Llames, S. G., M. Del Rio, et al. (2004). "Human plasma as a dermal scaffold 
for the generation of a completely autologous bioengineered skin." 
Transplantation 77(3): 350-355. 
Lu, C. P., L. Polak, et al. (2012). "Identification of stem cell populations in 
sweat glands and ducts reveals roles in homeostasis and wound repair." 
Cell 150(1): 136-150. 
Ludwig, T. E., M. E. Levenstein, et al. (2006). "Derivation of human 
embryonic stem cells in defined conditions." Nat Biotechnol 24(2): 
185-187. 
Lyle, S., M. Christofidou-Solomidou, et al. (1998). "The C8/144B monoclonal 
antibody recognizes cytokeratin 15 and defines the location of human 
hair follicle stem cells." J Cell Sci 111 ( Pt 21): 3179-3188. 
135 
 
Mackenzie, I. C. (1970). "Relationship between mitosis and the ordered 
structure of the stratum corneum in mouse epidermis." Nature 
226(5246): 653-655. 
Mackenzie, I. C. and J. R. Bickenbach (1985). "Label-retaining keratinocytes 
and Langerhans cells in mouse epithelia." Cell Tissue Res 242(3): 551-
556. 
Marconi, A., K. Dallaglio, et al. (2007). "Survivin identifies keratinocyte stem 
cells and is downregulated by anti-beta1 integrin during anoikis." Stem 
Cells 25(1): 149-155. 
Marston, W. A., J. Hanft, et al. (2003). "The efficacy and safety of Dermagraft 
in improving the healing of chronic diabetic foot ulcers: results of a 
prospective randomized trial." Diabetes Care 26(6): 1701-1705. 
Martin, C. M., A. P. Meeson, et al. (2004). "Persistent expression of the ATP-
binding cassette transporter, Abcg2, identifies cardiac SP cells in the 
developing and adult heart." Dev Biol 265(1): 262-275. 
Martin, M. J., A. Muotri, et al. (2005). "Human embryonic stem cells express 
an immunogenic nonhuman sialic acid." Nat Med 11(2): 228-232. 
Mauch, C. (1998). "Regulation of connective tissue turnover by cell-matrix 
interactions." Arch Dermatol Res 290 Suppl: S30-36. 
Mavilio, F., G. Pellegrini, et al. (2006). "Correction of junctional 
epidermolysis bullosa by transplantation of genetically modified 
epidermal stem cells." Nat Med 12(12): 1397-1402. 
McAnulty, R. J. (2007). "Fibroblasts and myofibroblasts: their source, 
function and role in disease." Int J Biochem Cell Biol 39(4): 666-671. 
Meana, A., J. Iglesias, et al. (1998). "Large surface of cultured human 
epithelium obtained on a dermal matrix based on live fibroblast-
containing fibrin gels." Burns 24(7): 621-630. 
Michel, M., N. Torok, et al. (1996). "Keratin 19 as a biochemical marker of 
skin stem cells in vivo and in vitro: keratin 19 expressing cells are 
differentially localized in function of anatomic sites, and their number 
varies with donor age and culture stage." J Cell Sci 109 ( Pt 5): 1017-
1028. 
Miyake, K., L. Mickley, et al. (1999). "Molecular cloning of cDNAs which are 
highly overexpressed in mitoxantrone-resistant cells: demonstration of 
homology to ABC transport genes." Cancer Res 59(1): 8-13. 
Montanaro, F., K. Liadaki, et al. (2004). "Demystifying SP cell purification: 
viability, yield, and phenotype are defined by isolation parameters." 
Exp Cell Res 298(1): 144-154. 
Montanaro, F., K. Liadaki, et al. (2003). "Skeletal muscle engraftment 
potential of adult mouse skin side population cells." Proc Natl Acad 
Sci U S A 100(16): 9336-9341. 
Moore, K. A. and I. R. Lemischka (2006). "Stem cells and their niches." 
Science 311(5769): 1880-1885. 
Morris, R. J., S. M. Fischer, et al. (1985). "Evidence that the centrally and 
peripherally located cells in the murine epidermal proliferative unit are 
two distinct cell populations." J Invest Dermatol 84(4): 277-281. 
Morris, R. J., Y. Liu, et al. (2004). "Capturing and profiling adult hair follicle 
stem cells." Nat Biotechnol 22(4): 411-417. 
136 
 
Morris, R. J. and C. S. Potten (1994). "Slowly cycling (label-retaining) 
epidermal cells behave like clonogenic stem cells in vitro." Cell Prolif 
27(5): 279-289. 
Morris, R. J. and C. S. Potten (1999). "Highly persistent label-retaining cells 
in the hair follicles of mice and their fate following induction of 
anagen." J Invest Dermatol 112(4): 470-475. 
Morrison, S. J., D. E. Wright, et al. (1997). "Hematopoietic stem cells: 
challenges to expectations." Curr Opin Immunol 9(2): 216-221. 
Navsaria, H. A., N. O. Ojeh, et al. (2004). "Reepithelialization of a full-
thickness burn from stem cells of hair follicles micrografted into a 
tissue-engineered dermal template (Integra)." Plast Reconstr Surg 
113(3): 978-981. 
Nijhof, J. G., K. M. Braun, et al. (2006). "The cell-surface marker MTS24 
identifies a novel population of follicular keratinocytes with 
characteristics of progenitor cells." Development 133(15): 3027-3037. 
Ohyama, M., A. Terunuma, et al. (2006). "Characterization and isolation of 
stem cell-enriched human hair follicle bulge cells." J Clin Invest 
116(1): 249-260. 
Ortiz-Urda, S., B. Thyagarajan, et al. (2002). "Stable nonviral genetic 
correction of inherited human skin disease." Nat Med 8(10): 1166-
1170. 
Oshima, H., A. Rochat, et al. (2001). "Morphogenesis and renewal of hair 
follicles from adult multipotent stem cells." Cell 104(2): 233-245. 
Panteleyev, A. A., C. A. Jahoda, et al. (2001). "Hair follicle 
predetermination." J Cell Sci 114(Pt 19): 3419-3431. 
Pavlovitch, J. H., M. Rizk-Rabin, et al. (1991). "Characteristics of 
homogeneously small keratinocytes from newborn rat skin: possible 
epidermal stem cells." Am J Physiol 261(6 Pt 1): C964-972. 
Pearce, D. J., C. M. Ridler, et al. (2004). "Multiparameter analysis of murine 
bone marrow side population cells." Blood 103(7): 2541-2546. 
Pellegrini, G., M. De Luca, et al. (2007). "Towards therapeutic application of 
ocular stem cells." Semin Cell Dev Biol 18(6): 805-818. 
Pellegrini, G., E. Dellambra, et al. (2001). "p63 identifies keratinocyte stem 
cells." Proc Natl Acad Sci U S A 98(6): 3156-3161. 
Pittenger, M. F., A. M. Mackay, et al. (1999). "Multilineage potential of adult 
human mesenchymal stem cells." Science 284(5411): 143-147. 
Potten, C. S., D. Booth, et al. (2002). "Cell kinetic studies in murine ventral 
tongue epithelium: cell cycle progression studies using double 
labelling techniques." Cell Prolif 35 Suppl 1: 16-21. 
Potten, C. S. and J. H. Hendry (1973). "Letter: Clonogenic cells and stem cells 
in epidermis." Int J Radiat Biol Relat Stud Phys Chem Med 24(5): 537-
540. 
Potten, C. S., L. Kovacs, et al. (1974). "Continuous labelling studies on mouse 
skin and intestine." Cell Tissue Kinet 7(3): 271-283. 
Pouliot, N., N. A. Saunders, et al. (2002). "Laminin 10/11: an alternative 
adhesive ligand for epidermal keratinocytes with a functional role in 
promoting proliferation and migration." Exp Dermatol 11(5): 387-397. 
Redvers, R. P., A. Li, et al. (2006). "Side population in adult murine epidermis 
exhibits phenotypic and functional characteristics of keratinocyte stem 
cells." Proc Natl Acad Sci U S A 103(35): 13168-13173. 
137 
 
Rheinwald, J. G. and H. Green (1975). "Serial cultivation of strains of human 
epidermal keratinocytes: the formation of keratinizing colonies from 
single cells." Cell 6(3): 331-343. 
Richards, S., D. Leavesley, et al. (2008). "Development of defined media for 
the serum-free expansion of primary keratinocytes and human 
embryonic stem cells." Tissue Eng Part C Methods 14(3): 221-232. 
Richardson, G. D., E. C. Arnott, et al. (2005). "Plasticity of rodent and human 
hair follicle dermal cells: implications for cell therapy and tissue 
engineering." J Investig Dermatol Symp Proc 10(3): 180-183. 
Rinn, J. L., C. Bondre, et al. (2006). "Anatomic demarcation by positional 
variation in fibroblast gene expression programs." PLoS Genet 2(7): 
e119. 
Rinn, J. L., J. K. Wang, et al. (2008). "A systems biology approach to 
anatomic diversity of skin." J Invest Dermatol 128(4): 776-782. 
Robey, R. W., K. Steadman, et al. (2004). "Pheophorbide a is a specific probe 
for ABCG2 function and inhibition." Cancer Res 64(4): 1242-1246. 
Rocchi, E., A. Khodjakov, et al. (2000). "The product of the ABC half-
transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the 
plasma membrane." Biochem Biophys Res Commun 271(1): 42-46. 
Rochat, A., K. Kobayashi, et al. (1994). "Location of stem cells of human hair 
follicles by clonal analysis." Cell 76(6): 1063-1073. 
Ronfard, V., J. M. Rives, et al. (2000). "Long-term regeneration of human 
epidermis on third degree burns transplanted with autologous cultured 
epithelium grown on a fibrin matrix." Transplantation 70(11): 1588-
1598. 
Santoro, M. M. and G. Gaudino (2005). "Cellular and molecular facets of 
keratinocyte reepithelization during wound healing." Exp Cell Res 
304(1): 274-286. 
Scharenberg, C. W., M. A. Harkey, et al. (2002). "The ABCG2 transporter is 
an efficient Hoechst 33342 efflux pump and is preferentially expressed 
by immature human hematopoietic progenitors." Blood 99(2): 507-
512. 
Schinkel, A. H. and J. W. Jonker (2003). "Mammalian drug efflux transporters 
of the ATP binding cassette (ABC) family: an overview." Adv Drug 
Deliv Rev 55(1): 3-29. 
Schofield, R. (1983). "The stem cell system." Biomed Pharmacother 37(8): 
375-380. 
Singer, A. J. and R. A. Clark (1999). "Cutaneous wound healing." N Engl J 
Med 341(10): 738-746. 
Sorrell, J. M. and A. I. Caplan (2004). "Fibroblast heterogeneity: more than 
skin deep." J Cell Sci 117(Pt 5): 667-675. 
Stenderup, K., J. Justesen, et al. (2003). "Aging is associated with decreased 
maximal life span and accelerated senescence of bone marrow stromal 
cells." Bone 33(6): 919-926. 
Sudo, K., M. Kanno, et al. (2007). "Mesenchymal progenitors able to 
differentiate into osteogenic, chondrogenic, and/or adipogenic cells in 
vitro are present in most primary fibroblast-like cell populations." 
Stem Cells 25(7): 1610-1617. 
138 
 
Sun, T., M. Higham, et al. (2004). "Developments in xenobiotic-free culture of 
human keratinocytes for clinical use." Wound Repair Regen 12(6): 
626-634. 
Susanto, J., Y. H. Lin, et al. (2008). "Porphyrin homeostasis maintained by 
ABCG2 regulates self-renewal of embryonic stem cells." PLoS One 
3(12): e4023. 
Tani, H., R. J. Morris, et al. (2000). "Enrichment for murine keratinocyte stem 
cells based on cell surface phenotype." Proc Natl Acad Sci U S A 
97(20): 10960-10965. 
Taylor, G., M. S. Lehrer, et al. (2000). "Involvement of follicular stem cells in 
forming not only the follicle but also the epidermis." Cell 102(4): 451-
461. 
Terunuma, A., K. L. Jackson, et al. (2003). "Side population keratinocytes 
resembling bone marrow side population stem cells are distinct from 
label-retaining keratinocyte stem cells." J Invest Dermatol 121(5): 
1095-1103. 
Terunuma, A., V. Kapoor, et al. (2007). "Stem cell activity of human side 
population and alpha6 integrin-bright keratinocytes defined by a 
quantitative in vivo assay." Stem Cells 25(3): 664-669. 
Thomson, J. A., J. Itskovitz-Eldor, et al. (1998). "Embryonic stem cell lines 
derived from human blastocysts." Science 282(5391): 1145-1147. 
Toma, J. G., M. Akhavan, et al. (2001). "Isolation of multipotent adult stem 
cells from the dermis of mammalian skin." Nat Cell Biol 3(9): 778-
784. 
Trempus, C. S., R. J. Morris, et al. (2003). "Enrichment for living murine 
keratinocytes from the hair follicle bulge with the cell surface marker 
CD34." J Invest Dermatol 120(4): 501-511. 
Triel, C., M. E. Vestergaard, et al. (2004). "Side population cells in human and 
mouse epidermis lack stem cell characteristics." Exp Cell Res 295(1): 
79-90. 
Tumbar, T., G. Guasch, et al. (2004). "Defining the epithelial stem cell niche 
in skin." Science 303(5656): 359-363. 
Volk, E. L., K. M. Farley, et al. (2002). "Overexpression of wild-type breast 
cancer resistance protein mediates methotrexate resistance." Cancer 
Res 62(17): 5035-5040. 
Wan, H., M. G. Stone, et al. (2003). "Desmosomal proteins, including 
desmoglein 3, serve as novel negative markers for epidermal stem cell-
containing population of keratinocytes." J Cell Sci 116(Pt 20): 4239-
4248. 
Wang, G., H. Zhang, et al. (2005). "Noggin and bFGF cooperate to maintain 
the pluripotency of human embryonic stem cells in the absence of 
feeder layers." Biochem Biophys Res Commun 330(3): 934-942. 
Wang, H. J., T. M. Chen, et al. (1995). "Human keratinocyte culture using 
porcine pituitary extract in serum-free medium." Burns 21(7): 503-506. 
Waters, J. M., G. D. Richardson, et al. (2007). "Hair follicle stem cells." 
Semin Cell Dev Biol 18(2): 245-254. 
Watt, F. M. and B. L. Hogan (2000). "Out of Eden: stem cells and their 
niches." Science 287(5457): 1427-1430. 
139 
 
Wong, C. E., C. Paratore, et al. (2006). "Neural crest-derived cells with stem 
cell features can be traced back to multiple lineages in the adult skin." 
J Cell Biol 175(6): 1005-1015. 
Woodley, D. T., K. C. Wynn, et al. (1990). "Type IV collagen and fibronectin 
enhance human keratinocyte thymidine incorporation and spreading in 
the absence of soluble growth factors." J Invest Dermatol 94(1): 139-
143. 
Wright, W. E. and J. W. Shay (2002). "Historical claims and current 
interpretations of replicative aging." Nat Biotechnol 20(7): 682-688. 
Xu, C., M. S. Inokuma, et al. (2001). "Feeder-free growth of undifferentiated 
human embryonic stem cells." Nat Biotechnol 19(10): 971-974. 
Yano, S., Y. Ito, et al. (2005). "Characterization and localization of side 
population cells in mouse skin." Stem Cells 23(6): 834-841. 
Yao, S., S. Chen, et al. (2006). "Long-term self-renewal and directed 
differentiation of human embryonic stem cells in chemically defined 
conditions." Proc Natl Acad Sci U S A 103(18): 6907-6912. 
Yokoo, S., S. Yamagami, et al. (2008). "Human corneal epithelial equivalents 
for ocular surface reconstruction in a complete serum-free culture 
system without unknown factors." Invest Ophthalmol Vis Sci 49(6): 
2438-2443. 
Yokoo, S., S. Yamagami, et al. (2005). "Human corneal endothelial cell 
precursors isolated by sphere-forming assay." Invest Ophthalmol Vis 
Sci 46(5): 1626-1631. 
Zhao, R. C., L. Liao, et al. (2004). "Mechanisms of and perspectives on the 
mesenchymal stem cell in immunotherapy." J Lab Clin Med 143(5): 
284-291. 
Zhou, S., J. J. Morris, et al. (2002). "Bcrp1 gene expression is required for 
normal numbers of side population stem cells in mice, and confers 
relative protection to mitoxantrone in hematopoietic cells in vivo." 
Proc Natl Acad Sci U S A 99(19): 12339-12344. 
Zhou, S., J. D. Schuetz, et al. (2001). "The ABC transporter Bcrp1/ABCG2 is 
expressed in a wide variety of stem cells and is a molecular 








Name : Ma Dongrui 
Nationality: China 
Date of birth: 04.10.1972 
 
Education 
1998-2001, Master of Science, Peking Union Medical College (PUMC), 
Beijing, China. 




1. Chua AW, Ma D, Gan SU, et al. The role of R-spondin2 in 
keratinocyte proliferation and epidermal thickening in keloid scarring. J Invest 
Dermatol. 2011; 131(3):644-54. 
2. Chua AWC, Ma DR, Song IC, Phan TT, Lee ST & Song C. “In vitro 
evaluation of fibrin mat and TegadermTM wound dressing for the delivery of 
keratinocytes—Implications of their use to treat burns”, Burns, 34, 2008; 175-
180. 
3. DR Ma, EN Yang, ST Lee. A Review: The Location, Molecular 
Characterisation and Multipotency of Hair Follicle Epidermal Stem Cells. Ann 
Acad Med Singapore 2004;33:784-8. 
 
Conference presentations 
1. Ma Dongrui, Alvin Chua, Colin Song, S.T. Lee. “The molecular 
characterization of human epidermal stem cells with special reference 
to ABCG2 transporter gene”. The DUKE-NUS Scientific congress, 
2010, Singapore.  
2.  Ma Dongrui, Teo Peiyun, AWC Chua, S. T. Lee. “Expression of 
telomerase activity in human hair follicle sheath derived mesenchymal 
stem cells, comparison with bone marrow derived mesenchymal stem 
cells.” The 7th ISSCR annual meeting, July, 2009, Barcelona, Spain.   
141 
 
3. Ma Dongrui, Alvin Chua, Colin Song, Huynh Hung, S. T. Lee. 
“ABCG2 Identifies Clonogenic Keratinocytes In Human Interfollicular 
Skin Epidermis.” The 15th annual scientific meeting of SGH, April, 
2008, Singapore.  Selected for SGH Scientist Award, Runner up.  
4. Ma Dongrui, Lee S.T., AWC Chua, Yang Ennan. “Identification of the 
human hair follicle sheath as a niche for mesenchymal stem cells 
(MSC); A comparison with bone marrow derived MSCs.” The 5th 
ISSCR annual meeting, July 2007, Cairns, Australia. 
5. Ma Dongrui, Lee S. T., AWC Chua, Yang Ennan. “Side population 
cells in human skin identifies keratinocyte stem/progenitor cells.” The 
5th ISSCR annual meeting, July 2007, Cairns, Australia. 
6. Ma Dongrui, AWC Chua, Lee. S.T. “Characterization of ABCG2 
transporter in human iterfollicualr skin”. The 14th annual scientific 
meeting of SGH, April 2007, Singapore. Selected for Young 
Investigator Award, Finalist.  
7. Ma Dongrui, Lee S. T., AWC Chua, Yang Ennan, JC Kwok. 
“Characterization of human interfollicular epidermal stem cells with 
putative molecular markers.” The 4th ISSCR annual meeting June 
2006, Toronto.   
8.  Ma Dongrui, Yang Ennan, Alvin Chua, S.T. Lee. The expression of 
ABCG2 transporter in human interfollicle skin epidermis. The 3rd 
Annual Meeting of the International Society for Stem Cell Research, 






Microsoft office, Axiovision, Photoshop, Acrobat. 
 
Skill and interest 
Swimming, Running,  
 
